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Abstract	  	  
	  
The	  intestine	  is	  home	  to	  a	  large	  number	  of	  commensal	  microbes,	  which	  
are	  restricted	  to	  the	  intestinal	  lumen	  by	  the	  epithelial	  barrier.	  In	  the	  colon,	  which	  
has	  the	  greatest	  number	  of	  commensal	  microbes,	  the	  epithelial	  barrier	  is	  
maintained	  by	  turnover	  of	  the	  epithelium	  every	  3-­‐5	  days	  by	  a	  small	  population	  of	  
stem	  cells	  found	  at	  the	  base	  of	  the	  crypts.	  If	  bacteria	  are	  present	  in	  the	  lamina	  
propria,	  it	  indicates	  a	  loss	  of	  barrier	  integrity	  so	  it	  is	  important	  for	  the	  epithelium	  
to	  respond	  to	  this,	  to	  increase	  proliferation	  and	  repair	  the	  barrier	  to	  prevent	  
inflammation.	  Previous	  research	  indicates	  that	  stimulating	  pattern	  recognition	  
receptors,	  found	  on	  colonic	  stem	  cells,	  may	  be	  a	  mechanism	  by	  which	  epithelial	  
proliferation	  can	  be	  altered.	  	  
Here	  we	  have	  used	  human	  colonic	  organoids	  to	  determine	  if	  the	  colonic	  
bacteria	  modulate	  the	  proliferation	  of	  the	  colonic	  stem	  cells	  and	  hence	  the	  
properties	  of	  the	  colonic	  epithelium.	  Colonic	  organoids	  were	  grown	  from	  crypts	  
isolated	  from	  healthy	  patients	  and	  suspended	  in	  Matrigel®	  overlaid	  with	  a	  specific	  
stem	  cell	  growth	  media.	  Two	  distinct	  organoid	  types	  were	  seen	  in	  culture	  
enteroids,	  which	  have	  a	  well-­‐developed	  columnar	  epithelium	  and	  so	  appear	  to	  be	  
representative	  of	  the	  native	  colonic	  epithelium,	  and	  spheroids,	  which	  have	  a	  
poorly	  differentiated	  epithelium.	  The	  effect	  of	  the	  removal	  of	  the	  growth	  factor	  
Wnt3A,	  removal	  of	  the	  inhibitors	  of	  the	  TGF-­‐β	  pathway	  LY2157299	  and	  
SB202190,	  induction	  of	  differentiation	  by	  the	  addition	  of	  the	  γ-­‐secretase	  inhibitor	  
DAPT	  	  (10µm,	  [N-­‐[N-­‐(3,5-­‐difluorophenacetyl)-­‐l-­‐alanyl]-­‐S-­‐phenylglycine	  t-­‐butyl	  
ester),	  or	  inclusion	  of	  bacterial	  components	  including	  lipopolysaccharide	  (LPS),	  
lipoteichoic	  acid	  (LTA)	  flagellin	  and	  	  muramyl	  dipeptide	  (MDP)	  (all	  20ng	  ml-­‐1),	  in	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the	  growth	  media,	  on	  cell	  proliferation	  in	  enteroids	  was	  assessed	  by	  measurement	  
of	  the	  expression	  of	  proliferation-­‐associated	  genes	  (Cylcin	  D,	  p15,	  LTBP1,	  Ki67	  
LGR5,	  FOXM1	  and	  MYC)	  by	  qPCR.	  In	  addition,	  the	  incorporation	  of	  EdU	  (5-­‐ethynul-­‐
2’-­‐deoxyuridine)	  into	  the	  nuclei	  of	  dividing	  cells	  was	  used	  to	  quantify	  proliferation	  
in	  whole	  mounts	  of	  both	  spheroids	  and	  enteroids.	  Statistical	  significance	  was	  
determined	  by	  a	  Kruskal	  Wallis	  test	  and	  a	  Dunns	  post	  test	  or	  a	  Mann-­‐Whitney	  test.	  	  
	  Few	  changes	  in	  proliferation-­‐associated	  genes	  at	  the	  transcript	  level	  in	  
enteroids	  were	  seen,	  indicating	  environmental	  changes	  do	  not	  alter	  enteroid	  
proliferation.	  Consistent	  with	  the	  qPCR	  findings,	  direct	  quantification	  of	  cell	  
proliferation	  in	  whole	  mounts	  of	  enteroids,	  also	  found	  no	  significant	  change	  in	  
proliferation	  between	  control	  and	  experimentally	  treated	  enteroids.	  In	  contrast,	  
spheroids	  had	  a	  significantly	  higher	  rate	  of	  proliferation	  than	  enteroids	  (p<0.01).	  
Furthermore,	  a	  significant	  decrease	  in	  proliferation	  was	  seen	  in	  spheroids	  either	  
grown	  without	  Wnt3A	  (p<0.01),	  in	  the	  presence	  of	  DAPT	  (p<0.05),	  or	  with	  the	  
addition	  of	  LPS	  (P<0.05)	  and	  flagellin	  (p<0.01)	  for	  10	  days,	  compared	  to	  control	  
spheroids.	  	  
These	  results	  show	  that	  environmental	  changes	  can	  affect	  spheroid	  
proliferation;	  hence	  spheroids	  may	  be	  a	  better	  model	  of	  the	  crypt	  base,	  which	  is	  
the	  site	  of	  proliferation	  in	  the	  native	  epithelium.	  They	  also	  show	  there	  is	  a	  basal	  
level	  of	  proliferation	  maintained	  in	  the	  cultures,	  despite	  environmental	  
manipulations.	  Finally,	  these	  results	  show	  that	  the	  bacterial	  components	  LPS	  and	  
flagellin,	  which	  signal	  through	  TLR4	  and	  TLR5	  respectively,	  decrease	  colonic	  
proliferation,	  by	  directly	  interacting	  with	  the	  epithelium.	  A	  decrease	  in	  
proliferation	  under	  the	  conditions	  tested	  here	  was	  unexpected,	  and	  may	  highlight	  
	  
	  
iv	  
that	  other	  components	  such	  as	  immune	  or	  mesenchymal	  cells,	  may	  be	  important	  
in	  controlling	  colonic	  proliferation.	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1 Introduction	  
1.1 The	  intestine	  
The	  intestine	  is	  an	  important	  part	  of	  the	  human	  body,	  as	  it	  provides	  a	  vital	  
link	  between	  the	  internal	  environment	  and	  outside	  world.	  The	  role	  of	  the	  intestine	  
is	  in	  the	  selective	  absorption	  of	  nutrients,	  fluids	  and	  electrolytes,	  but	  in	  addition	  it	  
prevents	  the	  trillions	  of	  microbes	  in	  the	  lumen	  from	  entering	  our	  bodies.	  Due	  to	  its	  
important	  role	  in	  many	  aspects	  of	  health	  and	  disease,	  investigating,	  and	  better	  
understanding	  the	  functioning	  of	  the	  intestine	  has	  become	  an	  important	  research	  
area.	  Previously,	  this	  has	  focused	  on	  understanding	  how	  the	  small	  intestine	  
functions	  in	  both	  health	  and	  disease.	  The	  colon	  has	  also	  been	  studied,	  but	  to	  a	  
lesser	  extent,	  and	  the	  underlying	  mechanisms	  controlling	  a	  number	  of	  normal	  and	  
pathological	  responses	  are	  yet	  to	  be	  elucidated.	  
The	  colon	  is	  the	  most	  distal	  region	  of	  the	  intestine.	  It	  is	  roughly	  1.6	  meters	  
in	  length	  and	  consists	  of	  four	  regions,	  the	  cecum,	  ascending,	  transverse	  and	  
descending	  colon	  [41].	  The	  colon	  has	  a	  varied	  role,	  including	  the	  fermentation	  of	  
various	  indigestible	  carbohydrates	  and	  proteins,	  and	  maintaining	  the	  fluid	  and	  
electrolyte	  balance.	  	  
	  The	  intestine	  is	  a	  complex	  system,	  including	  the	  epithelium,	  the	  
underlying	  immune	  cells	  and	  the	  luminal	  microbiota,	  which	  work	  together	  to	  
regulate	  and	  maintain	  the	  appropriate	  conditions.	  This	  balance	  requires	  constant	  
communication	  between	  the	  epithelial	  cells,	  immune	  cells	  and	  the	  microbiota	  to	  
maintain	  cell	  proliferation,	  differentiation	  and	  death;	  but	  the	  mechanisms	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underlying	  these	  processes,	  and	  how	  they	  are	  changed	  in	  disease	  states	  still	  
remains	  elusive	  [57].	  	  	  
1.2 Intestinal	  microbiota	  
The	  lumen	  of	  the	  colon	  is	  home	  1014	  microbes,	  by	  far	  the	  largest	  number	  
in	  the	  body	  [82].	  The	  lumen	  is	  rapidly	  colonised	  post	  birth	  by	  these	  microbes,	  
including	  fungi,	  protozoa	  and	  bacteria	  (which	  make	  up	  the	  largest	  proportion	  of	  
the	  microbiota),	  with	  the	  composition	  varying	  between	  individuals	  [21].	  The	  
majority	  of	  the	  microbes	  are	  commensals,	  as	  they	  provide	  a	  digestive	  benefit	  to	  
the	  host	  by	  breaking	  down	  products	  such	  as	  polysaccharides,	  to	  produce	  short	  
chain	  fatty	  acids	  via	  fermentation	  [6].	  They	  also	  outcompete	  pathogens	  in	  a	  
number	  of	  ways	  to	  protect	  the	  host	  from	  pathogen-­‐associated	  diseases	  [21].	  
1.3 Intestinal	  immune	  system	  
Below	  the	  epithelium	  is	  a	  layer	  of	  loose	  connective	  tissue,	  the	  lamina	  
propria,	  which	  contains	  blood	  vessels,	  lymph	  drainage,	  nerves	  and	  intestinal	  
immune	  cells	  [56].	  The	  immune	  cells	  are	  important	  in	  removing	  any	  bacteria	  that	  
pass	  through	  the	  epithelium,	  before	  they	  trigger	  an	  inflammatory	  response.	  They	  
can	  generate	  both	  an	  adaptive	  and	  innate	  immune	  response,	  each	  of	  which	  is	  
associated	  with	  specific	  cell	  types.	  	  
Immune	  cells,	  along	  with	  the	  epithelial	  cells,	  express	  pattern	  recognition	  
receptors	  (PRRs),	  which	  bind	  foreign	  microbial	  components	  to	  generate	  an	  
immune	  response	  [16;	  21;	  51].	  PRRs	  include	  Toll-­‐like	  receptors	  (TLRs),	  NOD-­‐like	  
receptors	  (NLRs)	  and	  RIG-­‐like	  receptors	  (RLRs).	  Each	  PRR	  is	  able	  to	  bind	  a	  specific	  
microbial	  associated	  molecular	  pattern	  (MAMP),	  which	  are	  found	  exclusively	  on	  
microbes,	  and	  include	  components	  such	  as	  lipopolysaccharide	  (LPS)	  and	  flagellin.	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These	  MAMPs	  are	  found	  on	  both	  commensal	  microbiota	  and	  pathogens;	  however	  
having	  either	  in	  the	  lamina	  propria	  and	  underlying	  tissues	  has	  a	  negative	  effect	  on	  
host	  health.	  	  
1.4 The	  physical	  barrier	  
Having	  microbes	  and	  immune	  cells	  in	  such	  close	  proximity	  would	  be	  fatal	  
if	  there	  was	  no	  mechanism	  in	  place	  to	  prevent	  them	  from	  coming	  into	  direct	  
contact.	  A	  physical	  barrier	  made	  up	  of	  both	  mucus	  and	  the	  intestinal	  epithelial	  
cells	  compartmentalize	  the	  microbes	  away	  from	  the	  lamina	  propria	  and	  immune	  
cells,	  and	  is	  important	  in	  the	  maintenance	  of	  intestinal	  homeostasis	  and	  
prevention	  of	  disease.	  
1.4.1 Intestinal	  mucus	  layer	  
The	  mucus	  in	  the	  intestine	  covers	  the	  luminal	  surface	  of	  the	  epithelium,	  
and	  is	  produced	  by	  goblet	  cells,	  one	  of	  the	  mature	  intestinal	  cell	  types.	  It	  provides	  
a	  buffer	  area	  to	  keep	  the	  microbiota	  from	  being	  in	  direct	  contact	  with	  the	  
epithelium	  [64].	  The	  mucus	  in	  the	  colon	  forms	  two	  distinct	  layers,	  the	  inner	  layer	  
that	  is	  thin	  in	  diameter	  and	  dense,	  while	  the	  outer	  layer	  in	  contrast,	  is	  thicker	  in	  
diameter	  but	  less	  dense	  and	  contains	  relatively	  lower	  concentrations	  of	  mucin	  2	  
(MUC2)	  (Fig.	  1.1)	  [5;	  37;	  36].	  This	  difference	  in	  densities	  also	  affects	  the	  microbial	  
load	  within	  the	  two	  layers.	  As	  the	  inner	  layer	  is	  so	  dense,	  it	  limits	  the	  number	  of	  
bacteria	  that	  are	  able	  to	  pass	  into	  it,	  further	  reducing	  the	  contact	  between	  the	  
microbes	  and	  epithelium	  [37].	  In	  comparison,	  the	  outer	  layer	  is	  less	  dense,	  and	  
therefore	  provides	  an	  environment	  that	  allows	  the	  survival	  of	  a	  number	  of	  the	  
luminal	  microbes,	  where	  they	  carry	  out	  their	  digestive	  processes,	  ultimately	  
benefiting	  the	  host.	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1.4.1.1 	  Antimicrobials	  
The	  production	  of	  antimicrobials	  is	  another	  mechanism	  that	  restricts	  the	  
translocation	  of	  microbes	  across	  the	  epithelium.	  These	  are	  secreted	  into	  the	  
mucus	  and	  include	  immunoglobulin	  A	  (IgA)	  and	  human	  β-­‐defensins,	  which	  kill	  
bacteria	  that	  come	  near	  the	  epithelium,	  further	  limiting	  their	  attachment	  and	  
invasion	  [55;	  59;	  48].	  IgA	  is	  synthesised	  by	  activated	  B-­‐cells	  and	  released	  into	  the	  
lamina	  propria.	  Here	  it	  binds	  to	  its	  receptor	  on	  the	  basolateral	  membrane	  of	  
epithelial	  cells,	  and	  is	  transported	  across	  the	  epithelium	  to	  be	  secreted	  into	  the	  
mucus	  as	  secretory	  IgA	  (sIgA)	  [59;	  22;	  49;	  9;	  69].	  	  
β-­‐defensins	  are	  also	  secreted	  into	  the	  mucus,	  but	  unlike	  sIgA,	  they	  are	  
synthesised	  by	  epithelial	  cells	  in	  a	  constitutive	  manner,	  or	  in	  response	  to	  pro-­‐
inflammatory	  cytokines	  such	  as	  TNFα,	  or	  inflammatory	  stimuli	  such	  as	  LPS	  [63;	  
28].	  They	  kill	  bacteria	  by	  forming	  holes	  in	  microbial	  membranes,	  resulting	  in	  cell	  
lysis,	  preventing	  colonisation	  and	  associated	  inflammation	  [46;	  39].	  Ultimately	  
both	  sIgA	  and	  β-­‐defensins	  help	  to	  inhibit	  bacteria	  reaching	  and	  passing	  through	  
the	  epithelial	  barrier.	  
1.4.2 Intestinal	  epithelium	  
The	  number	  of	  mechanisms	  in	  place	  to	  prevent	  the	  immune	  cells	  and	  
microbes	  coming	  into	  contact	  highlight	  the	  importance	  of	  the	  barrier	  function	  in	  
maintaining	  normal	  conditions	  and	  preventing	  disease.	  Of	  this	  barrier,	  the	  
epithelial	  cells	  are	  the	  most	  important	  factor,	  as	  they	  not	  only	  provide	  a	  physical	  
barrier,	  but	  also	  control	  the	  regeneration	  and	  composition	  of	  the	  barrier	  itself.	  
The	  colonic	  epithelium	  is	  a	  single	  layer	  of	  polarised	  cells,	  which	  do	  not	  
form	  flat	  sheets,	  but	  instead	  fold	  down	  into	  the	  lamina	  propria	  to	  form	  crypts	  (Fig.	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1.1)	  [11;	  52;	  4;	  21;	  64].	  At	  the	  base	  of	  the	  crypts	  are	  a	  small	  number	  of	  cycling	  
adult	  stem	  cells,	  the	  division	  of	  which	  results	  in	  the	  generation	  of	  transit-­‐
amplifying	  (TA)	  cells	  (Fig.	  1.1)	  [11;	  52;	  21;	  87].	  TA	  cells	  are	  important	  as	  they	  are	  
the	  most	  rapidly	  proliferating	  cells	  in	  the	  colon,	  and	  are	  able	  to	  quickly	  amplify	  in	  
numbers.	  As	  they	  divide	  they	  move	  up	  the	  crypt,	  and	  away	  from	  the	  stem	  cell	  
niche.	  They	  respond	  to	  environmental	  cues	  from	  a	  number	  of	  signalling	  pathways,	  
that	  affect	  whether	  they	  enter	  the	  absorptive	  or	  secretory	  lineage	  and	  ultimately	  
which	  mature	  cell	  type	  they	  become	  when	  they	  reach	  the	  intercrypt	  table,	  the	  
flattened	  area	  between	  the	  tops	  of	  the	  crypts	  [8].	  	  
There	  are	  two	  distinct	  cell	  lineages	  in	  the	  colon;	  absorptive	  or	  secretory.	  
The	  absorptive	  lineage	  includes	  colonocytes,	  which	  take	  up	  nutrients,	  water	  and	  
salts	  from	  the	  lumen	  and	  transports	  them	  into	  the	  body	  (Fig.	  1.1)	  [64].	  The	  
secretory	  lineage,	  includes	  goblet	  cells,	  which	  have	  an	  important	  role	  in	  barrier	  
formation	  by	  secreting	  mucus	  onto	  the	  luminal	  side	  of	  the	  epithelium,	  and	  
enteroendocrine	  cells,	  which	  secrete	  a	  range	  of	  hormones	  such	  as	  secretin,	  that	  
play	  a	  role	  in	  the	  regulation	  of	  colonic	  function	  (Fig.	  1.1)	  [7].	  	  
Aside	  from	  providing	  a	  barrier,	  the	  epithelium	  also	  allows	  the	  absorption	  
of	  nutrients,	  electrolytes	  and	  products	  of	  fermentation,	  which	  occurs	  via	  specific	  
transporters	  on	  both	  the	  apical	  and	  basolateral	  membrane	  of	  colonocytes.	  Due	  to	  
the	  specificity	  of	  the	  transporters,	  microbial	  antigens	  are	  unable	  to	  pass	  through	  
the	  epithelial	  layer	  via	  this	  mechanism,	  as	  they	  are	  unable	  to	  bind	  to	  the	  
transporters,	  and	  subsequently	  be	  transferred	  through	  the	  epithelial	  cells	  and	  into	  
the	  lamina	  propria	  [55].	  However,	  as	  the	  epithelium	  is	  made	  up	  of	  a	  number	  of	  
cells	  joined	  together,	  rather	  than	  one	  continuous	  cell,	  this	  provides	  an	  alternate	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pathway	  for	  absorption,	  the	  paracellular	  pathway.	  Protein	  complexes	  called	  tight	  
junctions	  regulate	  the	  permeability	  of	  this	  pathway.	  These	  do	  not	  bind	  specific	  
nutritional	  components,	  but	  rather	  regulate	  transport	  based	  on	  size	  and	  charge	  [2;	  
14].	  	  
Tight	  junctions	  are	  made	  up	  a	  number	  of	  proteins	  including	  occludins,	  
claudins	  and	  junctional	  adhesion	  molecules	  (JAMs),	  which	  interact	  within	  and	  
between	  the	  epithelial	  cells	  to	  hold	  them	  together	  [27;	  26;	  53;	  23].	  These	  
components	  also	  determine	  the	  selectivity	  of	  this	  pathway,	  and	  subsequently	  what	  
is	  able	  to	  pass	  between	  the	  cells	  [15].	  This	  is	  important	  in	  barrier	  functioning	  as	  
increasing	  the	  permeability	  of	  tight	  junctions	  can	  result	  in	  an	  increase	  in	  bacterial	  
antigens	  passing	  across	  the	  epithelium,	  leading	  to	  immune	  cell	  activation	  [35].	  
	  
Figure	  1.1:	  Colonic	  crypt	  structure	  
	   7	  
Schematic	  diagram	  representing	  the	  colonic	  crypt	  structure	  A)	  Representative	  diagram	  of	  the	  close	  
up	  crypt	  structure	  showing	  the	  different	  cell	  types	  making	  up	  the	  crypt	  and	  the	  relationship	  
between	  the	  mucus,	  microbes	  and	  immune	  cells.	  B)	  Shows	  a	  lower	  scale	  image	  of	  the	  colonic	  
epithelial	  structure,	  with	  the	  zoomed	  in	  portion	  seen	  in	  A)	  highlighted	  in	  red.	  
1.4.2.1 Epithelial	  turnover	  
While	  it	  is	  recognised	  that	  the	  intestinal	  epithelium	  forms	  a	  physical	  
barrier,	  what	  is	  less	  apparent	  is	  that	  the	  maintenance	  of	  this	  barrier	  is	  critically	  
dependent	  on	  the	  constant	  turnover	  of	  the	  epithelium.	  Being	  able	  to	  regenerate	  
the	  epithelium	  and	  therefore	  the	  entire	  barrier	  is	  important	  in	  maintaining	  a	  
continuous	  layer	  that	  is	  undamaged,	  to	  limit	  bacteria	  passing	  through	  the	  barrier	  
and	  causing	  inflammation	  [1].	  To	  do	  this,	  the	  epithelium	  is	  in	  a	  constant	  state	  of	  
renewal	  and	  turnover,	  with	  both	  stem	  cell	  and	  TA	  cell	  proliferation	  resulting	  in	  the	  
full	  replacement	  of	  the	  colonic	  epithelium	  every	  3-­‐5	  days	  [8].	  	  
The	  proliferation	  of	  the	  stem	  cells	  maintains	  the	  physical	  barrier	  and	  
allows	  its	  repair.	  If	  the	  barrier	  becomes	  damaged,	  luminal	  microbes	  can	  pass	  into	  
the	  lamina	  propria	  [1].	  Here	  they	  can	  activate	  immune	  cells,	  and	  if	  the	  bacteria	  are	  
not	  rapidly	  cleared,	  inflammation	  can	  follow	  [74].	  Regulating	  this	  proliferation,	  to	  
subsequently	  regulate	  the	  barrier	  is	  therefore	  vital.	  The	  control	  of	  proliferation	  of	  
colonic	  stem	  cells	  is	  a	  complex	  process,	  with	  many	  pathways	  that	  have	  been	  
potentially	  implicated	  in	  its	  control.	  Due	  to	  the	  complexity	  however,	  the	  control	  of	  
colonic	  stem	  cell	  proliferation	  under	  normal	  conditions,	  and	  how	  it	  is	  altered	  in	  
pathologies	  such	  as	  inflammatory	  bowel	  disease	  is	  still	  to	  be	  elucidated.	  	  	  
1.5 Cell	  cycle	  
Proliferation	  of	  the	  colonic	  epithelium	  is	  important	  as	  it	  contributes	  to	  
controlling	  barrier	  functioning	  and	  limiting	  bacterial	  components	  from	  interacting	  
with	  immune	  cells.	  For	  the	  stem	  cells	  to	  proliferate,	  they	  must	  pass	  a	  number	  of	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checkpoints	  and	  progress	  through	  all	  phases	  of	  the	  cell	  cycle,	  to	  divide	  and	  
generate	  daughter	  cells.	  	  
The	  cell	  cycle	  involves	  two	  overarching	  phases,	  mitosis,	  or	  M	  phase	  which	  
consists	  of	  prophase,	  metaphase,	  anaphase,	  telophase	  and	  cytokinesis;	  and	  
interphase,	  which	  is	  further	  subdivided	  into	  G1,	  S	  and	  G2	  phases	  (Fig.	  1.2)	  [77;	  
84].	  G1	  and	  G2	  are	  called	  gap	  phases,	  and	  are	  when	  the	  cell	  is	  preparing	  for	  DNA	  
replication	  or	  mitosis	  respectively.	  S	  phase	  is	  also	  known	  as	  the	  synthesis	  phase,	  
and	  is	  when	  the	  DNA	  is	  synthesised	  for	  replication.	  	  
The	  cell	  cycle	  is	  tightly	  regulated	  by	  cyclin	  dependent	  kinases	  (cdks),	  and	  
the	  cyclins	  that	  bind	  to	  them	  (Fig.	  1.2)	  [77].	  Each	  cyclin	  is	  produced	  cyclically	  
during	  the	  cell	  cycle	  to	  tightly	  regulate	  the	  transition	  from	  phase	  to	  phase,	  and	  a	  
combination	  of	  cyclins	  and	  cdks	  are	  specific	  to	  each	  phase;	  e.g.	  cdk4	  and	  6	  and	  
cyclin	  D1-­‐3	  are	  specifically	  produced	  during	  G1	  phase	  [84].	  There	  are	  also	  
checkpoints	  at	  various	  places	  to	  ensure	  there	  is	  no	  damage	  to	  the	  DNA,	  before	  
progressing	  through	  the	  cell	  cycle,	  to	  prevent	  pathological	  changes	  (Fig.	  1.2).	  
Inhibitors,	  such	  as	  the	  INK4	  family	  including	  p15,	  can	  be	  up	  regulated	  in	  response	  
to	  a	  number	  of	  stimuli	  to	  stop	  cell	  cycle	  progression	  if	  DNA	  damage	  or	  other	  
problems	  are	  detected	  [77;	  84].	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Figure	  1.2:	  The	  cell	  cycle,	  cyclins	  and	  cyclin	  dependent	  kinases	  
Schematic	  diagrams	  showing	  the	  cell	  cycle	  and	  the	  interaction	  between	  cyclins	  and	  cdks	  A)	  A	  
representative	  diagram	  of	  the	  cell	  cycle	  including	  the	  two	  overarching	  phases,	  mitosis	  and	  
interphase,	  as	  well	  as	  the	  many	  phases	  they	  are	  broken	  into.	  Red	  arrows	  indicate	  checkpoints	  in	  
the	  cell	  cycle	  where	  DNA	  is	  checked	  for	  damage,	  correct	  replication	  and	  chromosome	  segregation	  
before	  the	  cell	  cycle	  can	  progress.	  B)	  Shows	  the	  interaction	  between	  cyclins	  and	  cdks,	  important	  
regulators	  of	  all	  phases	  of	  the	  cell	  cycle.	  Cyclins	  are	  cyclically	  produced,	  so	  they	  can	  then	  bind	  to	  
their	  corresponding	  cdk	  to	  become	  active	  and	  elicit	  a	  response,	  ultimately	  allowing	  cell	  cycle	  
progression.	  	  
1.6 Control	  of	  proliferation	  
Maintaining	  the	  dynamic	  state	  of	  the	  colon,	  to	  ensure	  turnover	  to	  replace	  
damaged	  or	  lost	  cells	  is	  important	  in	  maintaining	  the	  colonic	  barrier.	  Mechanisms	  
must	  therefore	  be	  in	  place	  to	  regulate	  the	  rate	  of	  proliferation	  of	  the	  stem	  cell	  and	  
TA	  cell	  population,	  to	  subsequently	  regulate	  the	  barrier	  in	  response	  to	  stimuli.	  For	  
example,	  in	  the	  presence	  of	  damage,	  and	  a	  subsequent	  influx	  of	  bacteria	  across	  the	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epithelium,	  it	  would	  make	  sense	  to	  up	  regulate	  proliferation	  in	  order	  to	  repair	  the	  
barrier	  and	  restore	  normal	  conditions,	  limiting	  inflammation.	  There	  are	  a	  number	  
of	  mechanisms	  in	  place	  to	  control	  proliferation	  and	  therefore	  entry	  into	  the	  cell	  
cycle,	  as	  well	  as	  the	  differentiation	  of	  epithelial	  cells	  and	  their	  subsequent	  cell	  
cycle	  arrest.	  Along	  with	  this,	  the	  loss	  of	  damaged	  cells	  via	  apoptosis	  is	  also	  tightly	  
regulated	  to	  maintain	  the	  barrier	  function.	  If	  these	  processes	  become	  deregulated	  
due	  to	  genetic	  changes	  or	  external	  influence,	  the	  balance	  can	  be	  lost	  and	  the	  
barrier	  can	  become	  impaired.	  	  
1.6.1 Canonical	  Wnt	  signalling	  
The	  Canonical	  Wnt	  pathway	  has	  a	  central	  role	  in	  the	  regulation	  of	  
proliferation	  and	  cell	  cycle	  progression	  in	  the	  colon	  [66;	  44;	  70;	  71].	  Inhibiting	  this	  
pathway,	  for	  example	  by	  overexpressing	  DKK1	  (Dickkopf	  Homolog	  1),	  a	  secreted	  
Wnt	  antagonist,	  prevents	  proliferation	  and	  causes	  a	  loss	  of	  the	  proliferative	  zone	  
within	  the	  crypt	  structure,	  while	  agonists	  of	  the	  pathway,	  such	  as	  R-­‐spondin,	  
amplify	  the	  proliferative	  effects	  [66].	  In	  vivo,	  Wnt	  is	  produced	  by	  the	  mesenchymal	  
cells	  [31].	  Without	  Wnt,	  the	  receptor	  is	  not	  activated	  and	  thus	  the	  major	  
downstream	  signalling	  molecule,	  β-­‐catenin	  becomes	  phosphorylated	  by	  the	  
kinases	  within	  the	  destruction	  complex	  in	  the	  cytoplasm	  of	  the	  cell,	  causing	  β-­‐
catenin	  degradation	  in	  the	  proteasome	  (Fig.	  1.3)	  [72].	  This	  means	  β-­‐catenin	  
cannot	  translocate	  to	  the	  nucleus	  and	  therefore	  Wnt	  target	  genes	  remain	  
repressed	  [70].	  If	  Wnt	  is	  present,	  it	  binds	  to	  its	  receptor,	  preventing	  the	  
destruction	  complex	  forming	  (Fig.	  1.3).	  As	  a	  result,	  β-­‐catenin	  accumulates	  in	  the	  
cytoplasm,	  moves	  to	  the	  nucleus	  and	  activates	  Wnt	  target	  genes,	  many	  of	  which	  
have	  been	  associated	  with	  proliferation	  and	  cell	  cycle	  control	  [3;	  31].	  This	  means	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that	  the	  stem	  cells	  remain	  at	  the	  base	  of	  the	  crypt,	  close	  to	  the	  mesenchyme	  and	  
therefore	  in	  the	  presence	  of	  high	  concentrations	  of	  Wnt,	  so	  are	  maintained	  in	  a	  
proliferative	  state.	  As	  the	  cells	  divide	  and	  are	  pushed	  up	  the	  crypt	  away	  from	  the	  
base,	  they	  move	  further	  away	  from	  the	  mesenchyme,	  into	  decreasing	  
concentrations	  of	  Wnt,	  and	  instead	  become	  influenced	  by	  other	  pathways,	  
resulting	  in	  differentiation	  of	  the	  progenitor	  cell	  population.	  
	  
Figure	  1.3:	  The	  canonical	  Wnt	  signalling	  pathway	  	  
Schematic	  diagrams	  showing	  the	  Wnt	  signalling	  pathway	  in	  the	  presence	  and	  absence	  of	  Wnt.	  
Without	  Wnt,	  β-­‐catenin	  becomes	  degraded,	  so	  Wnt	  target	  genes,	  some	  of	  which	  are	  associated	  with	  
proliferation,	  are	  unable	  to	  be	  transcribed.	  In	  contrast,	  in	  the	  presence	  of	  Wnt,	  β-­‐catenin	  is	  not	  
degraded,	  but	  instead	  accumulates	  in	  the	  cytoplasm,	  translocates	  to	  the	  nucleus	  and	  activates	  Wnt	  
target	  genes,	  therefore	  increasing	  proliferation.	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1.6.2 The	  transforming	  growth	  factor-­‐β	  (TGF-­‐β)	  pathway	  
Another	  pathway	  that	  is	  associated	  with	  proliferative	  control,	  more	  
specifically	  by	  inhibiting	  proliferation	  is	  the	  TGF-­‐β	  pathway	  [73].	  TGF-­‐β	  is	  released	  
into	  the	  cytoplasm	  as	  part	  of	  an	  inactive	  complex	  [19].	  This	  prevents	  any	  
unintended	  activation	  of	  the	  pathway,	  but	  allows	  the	  inactive	  form	  to	  act	  as	  a	  
reservoir,	  ready	  to	  become	  rapidly	  active	  without	  the	  need	  to	  be	  synthesised.	  
Proteases	  act	  to	  degrade	  the	  pro-­‐segments	  of	  the	  TGF-­‐β	  latent	  complex,	  to	  cause	  
its	  activation.	  It	  then	  binds	  its	  receptor	  to	  activate	  a	  number	  of	  downstream	  
targets,	  mainly	  by	  phosphorylation	  [19;	  80].	  One	  of	  the	  main	  targets	  of	  the	  TGF-­‐β	  
pathway	  include	  a	  family	  of	  SMADS,	  especially	  SMAD2,	  3	  and	  4	  (Fig.	  1.4),	  which	  
become	  phosphorylated	  and	  interact	  together	  to	  generate	  a	  number	  of	  effects,	  
including	  interacting	  with	  the	  important	  Wnt	  pathway	  component	  β-­‐catenin	  [19].	  	  
It	  is	  well	  known	  that	  TGF-­‐β	  plays	  a	  role	  in	  inhibiting	  proliferation	  in	  
mature	  tissues	  such	  as	  epithelia,	  as	  mutations	  causing	  inhibition	  of	  the	  TGF-­‐β	  
pathway	  in	  cancer	  results	  in	  an	  increase	  in	  proliferation	  [73].	  Activation	  of	  the	  
TGF-­‐β	  pathway	  also	  causes	  inhibition	  of	  the	  Wnt	  target	  gene	  MYC.	  MYC	  is	  normally	  
found	  bound	  to	  cyclin	  dependent	  kinase	  inhibitors,	  helping	  to	  aid	  in	  cell	  cycle	  
progression	  [80].	  The	  inhibition	  of	  MYC	  by	  TGF-­‐β	  activation,	  results	  in	  the	  release	  
of	  the	  cyclin	  dependent	  kinases	  inhibitors	  from	  MYC	  inhibition,	  leading	  to	  cell	  
cycle	  inhibition	  and	  ultimately	  arrest	  at	  the	  G1	  phase,	  causing	  cellular	  
differentiation.	  	  
The	  TGF-­‐β	  pathway	  producing	  cyclin	  dependent	  kinase	  inhibitors	  such	  as	  
p15	  amplifies	  this	  proliferative	  arrest	  (Fig.	  1.4).	  These	  molecules	  also	  regulate	  the	  
cell	  cycle	  by	  inhibiting	  a	  number	  of	  cyclins	  and	  therefore	  affecting	  cell	  cycle	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progression	  [54;	  10;	  80].	  Overall	  TGF-­‐β	  acts	  in	  a	  number	  of	  ways	  to	  alter	  the	  cell	  
cycle	  and	  therefore	  the	  balance	  between	  proliferation	  and	  differentiation.	  
	  
Figure	  1.4:	  The	  TGF-­‐β	  pathway	  
Schematic	  diagrams	  showing	  the	  TGF-­‐β	  pathway,	  a	  pathway	  associated	  with	  decreased	  
proliferation.	  Activation	  of	  this	  pathway	  results	  in	  the	  phosphorylation	  of	  SMAD	  proteins,	  and	  the	  
subsequent	  transcription	  of	  a	  number	  of	  genes	  including	  the	  cell	  cycle	  inhibitor	  p15.	  p15	  is	  able	  to	  
bind	  to	  MYC,	  preventing	  it	  inhibiting	  cell	  cycle	  inhibitors,	  therefore	  causing	  an	  increase	  in	  cell	  cycle	  
inhibition	  and	  a	  decrease	  in	  proliferation.	  	  
1.6.3 The	  Notch	  pathway	  	  
The	  Notch	  pathway	  plays	  a	  number	  of	  roles	  in	  varying	  tissues,	  although	  
evidence	  is	  building	  to	  show	  its	  dual	  role	  in	  both	  proliferation	  and	  differentiation	  
in	  the	  intestine.	  [58].	  In	  Notch	  signalling,	  a	  ligand	  binds	  to	  the	  Notch	  receptor,	  
resulting	  in	  the	  cleavage	  of	  the	  intracellular	  domain	  by	  γ-­‐secretase	  (Fig.	  1.5)	  [17;	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58].	  The	  intracellular	  domain	  is	  then	  able	  to	  translocate	  to	  the	  nucleus	  and	  
activate	  transcription	  of	  a	  number	  of	  genes,	  such	  as	  HES1.	  	  
Transgenic	  activation	  of	  the	  Notch	  pathway,	  results	  in	  a	  decrease	  in	  the	  
number	  of	  secretory	  cells	  within	  the	  intestinal	  epithelium.	  This	  is	  due	  to	  an	  
increase	  is	  HES1,	  causing	  increased	  inhibition	  of	  the	  Wnt	  target	  gene	  ATOH1,	  a	  
gene	  which	  is	  important	  in	  secretory	  lineage	  development.	  Aside	  from	  this,	  
activation	  of	  the	  Notch	  pathway	  also	  results	  in	  an	  increase	  in	  the	  number	  of	  
proliferating	  cells,	  accompanied	  by	  an	  increase	  in	  the	  proliferative	  zone	  within	  the	  
crypt	  [24;	  83].	  The	  converse	  has	  been	  shown	  where	  disrupting	  Notch	  signalling	  
with	  γ-­‐secretase	  inhibitors,	  results	  in	  a	  marked	  increase	  in	  the	  number	  of	  
secretory	  cells	  such	  as	  goblet	  cells,	  along	  with	  a	  loss	  of	  both	  proliferative	  cells	  and	  
the	  proliferative	  zone	  within	  the	  crypt	  [24;	  83].	  It	  is	  important	  to	  note	  with	  Notch	  
activation,	  the	  Wnt	  pathway	  must	  also	  be	  kept	  active	  to	  maintain	  the	  proliferative	  
progenitors,	  although	  the	  exact	  mechanism	  by	  which	  this	  occurs	  is	  still	  unknown	  
[83].	  	  
At	  the	  base	  of	  the	  crypt,	  both	  Wnt	  and	  Notch	  signalling	  are	  high,	  and	  as	  
progenitors	  move	  away	  from	  the	  crypt	  base,	  they	  also	  move	  away	  from	  Wnt	  
signalling	  so	  begin	  to	  differentiate.	  Then	  by	  responding	  to	  other	  stimuli,	  Notch	  
signalling	  remains	  on,	  or	  is	  switched	  off	  to	  further	  determine	  the	  fate	  of	  the	  
differentiated	  cell.	  Therefore	  proliferation	  can	  be	  further	  regulated	  by	  Notch	  
signalling	  within	  the	  base	  of	  the	  crypts,	  and	  escaping	  	  from	  Notch	  signalling	  can	  
cause	  a	  loss	  of	  proliferation.	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Figure	  1.5:	  The	  Notch	  signalling	  pathway	  	  
Schematic	  diagrams	  showing	  the	  Notch	  signalling	  pathway.	  Activation	  of	  the	  pathway	  results	  in	  
cleavage	  of	  the	  intracellular	  domain	  by	  γ-­‐secretase.	  This	  subsequently	  activates	  a	  number	  of	  
downstream	  genes,	  including	  HES1,	  which,	  in	  the	  presence	  of	  Wnt	  pathway	  signalling,	  work	  
together	  to	  maintain	  stem	  cell	  proliferation	  and	  inhibit	  differentiation.	  
1.6.4 Influence	  of	  bacteria	  on	  proliferation	  
With	  the	  high	  number	  of	  bacteria	  present	  in	  the	  lumen	  of	  the	  colon,	  it	  is	  
becoming	  increasingly	  evident	  that	  they	  can	  interact	  with	  the	  epithelium	  to	  
modulate	  its	  response	  to	  stimuli,	  including	  through	  varying	  epithelial	  
proliferation.	  Epithelial	  cells,	  including	  stem	  cells,	  have	  PRRs	  on	  their	  surface,	  
providing	  a	  mechanism	  by	  which	  this	  regulation	  could	  occur	  [1].	  The	  luminal	  side	  
of	  the	  epithelium	  is	  constantly	  exposed	  to	  relatively	  high	  concentrations	  of	  
microbes.	  In	  contrast,	  the	  serosal	  side	  is	  exposed	  to	  much	  lower	  concentrations,	  
with	  fluctuations	  occurring	  only	  when	  bacteria	  pass	  through	  the	  epithelium,	  for	  
example	  if	  it	  were	  damaged.	  Therefore	  alterations	  in	  serosal	  microbial	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concentrations,	  assessed	  via	  PRRs,	  may	  provide	  a	  way	  to	  signal	  changes	  in	  the	  
efficacy	  of	  the	  barrier.	  This	  could	  then	  modulate	  stem	  cell	  proliferation	  to	  repair	  
any	  damage.	  
	  Mice	  that	  have	  been	  raised	  in	  a	  germ	  free	  environment	  have	  decreased	  
epithelial	  proliferation	  compared	  with	  mice	  that	  have	  a	  normal	  flora,	  indicating	  
proliferation	  can	  be	  regulated	  by	  microbes	  [1].	  Despite	  this,	  little	  is	  known	  about	  
how	  the	  different	  bacterial	  components	  affect	  proliferation	  of	  the	  stem	  cells.	  A	  
number	  of	  bacterial	  MAMPs	  could	  be	  implicated	  in	  mediating	  proliferative	  
changes.	  These	  include	  lipopolysaccharide	  (LPS),	  a	  component	  of	  gram-­‐negative	  
bacteria,	  which	  activates	  TLR4,	  or	  flagellin,	  from	  flagellated	  bacteria,	  that	  activates	  
TLR5	  [30;	  13;	  60;	  74].	  Muramyl	  dipeptide	  (MDP)	  from	  both	  gram-­‐negative	  and	  
gram-­‐positive	  bacteria,	  along	  with	  lipoteichoic	  acid	  (LTA)	  from	  gram-­‐positive	  
bacteria,	  which	  activate	  NLRs	  and	  TLR2	  respectively	  could	  also	  be	  involved	  [34;	  
33].	  The	  available	  research	  is	  also	  inconclusive,	  as	  there	  evidence,	  for	  example,	  
that	  TLR	  stimulation	  both	  increases	  (Santaolalla	  et	  al.,	  2013)	  and	  decreases	  (Neal	  
et	  al.,	  2012)	  intestinal	  epithelial	  cell	  proliferation.	  	  	  
1.7 Modelling	  the	  intestinal	  epithelium	  
Due	  to	  the	  importance	  of	  stem	  cell	  proliferation	  in	  maintaining	  the	  normal	  
intestinal	  environment,	  being	  able	  to	  generate	  a	  good	  model	  to	  study	  this	  aspect	  is	  
important.	  There	  are	  a	  number	  of	  models	  that	  are	  currently	  used	  for	  studying	  
intestinal	  proliferation.	  Cell	  lines,	  including	  Caco-­‐2	  cells,	  have	  been	  used,	  but	  as	  
they	  grow	  in	  a	  flat	  sheet,	  they	  fail	  to	  generate	  a	  number	  of	  the	  physiological	  
characteristics	  seen	  in	  vivo	  [50].	  This	  includes	  being	  unable	  to	  produce	  all	  of	  the	  
differentiated	  cell	  types,	  due	  to	  being	  clonal	  in	  nature,	  therefore	  limiting	  the	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applicability	  of	  the	  findings.	  Animal	  models	  have	  also	  been	  used,	  including	  whole	  
mouse	  models	  and	  cultures	  of	  animal	  cells,	  however	  the	  physiological	  conditions	  
in	  animals	  often	  differs	  to	  that	  in	  humans,	  once	  again	  limiting	  the	  relevance	  of	  the	  
findings	  to	  humans	  [44].	  	  
An	  important	  advance	  in	  this	  area	  of	  research	  was	  the	  development	  of	  3-­‐D	  
cultures	  of	  the	  intestinal	  epithelium.	  These	  consist	  of	  either	  organoids,	  which	  are	  
grown	  from	  pluripotent	  stem	  cells,	  or	  enteroids,	  which	  are	  derived	  from	  adult	  
intestinal	  stem	  cells	  [87].	  Organoids	  from	  pluripotent	  stem	  cells	  replicate	  the	  
stages	  seen	  in	  intestinal	  development,	  and	  therefore	  provide	  a	  good	  model	  for	  
studying	  molecular	  events	  associated	  with	  the	  development	  of	  the	  intestine.	  They	  
also	  contain	  both	  the	  epithelium	  the	  underlying	  tissue	  including	  the	  mesenchymal	  
cells,	  so	  the	  interactions	  between	  these	  different	  cell	  types	  can	  be	  investigated.	  In	  
contrast,	  enteroids	  derived	  from	  adult	  stem	  cells,	  consist	  of	  the	  epithelium	  alone	  
and	  therefore	  provide	  an	  unparalleled	  model	  to	  study	  intestinal	  epithelial	  
processes,	  including	  stem	  cell	  proliferation.	  	  
The	  enteroid	  model	  was	  originally	  developed	  using	  mouse	  small	  intestinal	  
stem	  cells,	  however	  development	  of	  the	  technique	  has	  led	  to	  the	  ability	  to	  grow	  
enteroids	  from	  human	  adult	  colonic	  stem	  cells	  [62;	  76;	  75].	  These	  models	  rely	  on	  a	  
number	  of	  external	  growth	  factors	  to	  ensure	  long-­‐term	  growth	  of	  the	  enteroids,	  
and	  to	  support	  the	  proliferation	  of	  the	  stem	  cells	  and	  maintain	  their	  niche	  [38;	  75].	  
This	  provides	  insights	  into	  potential	  pathways	  that	  may	  play	  a	  role	  in	  maintaining	  
the	  physical	  barrier	  by	  controlling	  the	  proliferation,	  differentiation	  and	  death	  of	  
the	  intestinal	  stem	  cells	  and	  mature	  cell	  types,	  as	  well	  as	  highlighting	  the	  
importance	  in	  maintaining	  proliferation	  for	  normal	  colonic	  function	  [57].	  These	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models	  therefore	  provide	  a	  vital	  research	  tool	  to	  look	  into	  the	  normal	  functioning	  
of	  the	  intestinal	  epithelium	  and	  what	  processes	  become	  deregulated	  to	  cause	  
pathologies.	  
1.8 Aims	  and	  hypothesis	  
Previous	  research	  into	  understanding	  intestinal	  stem	  cell	  proliferation	  
has	  produced	  inconsistent	  results.	  A	  paper	  published	  by	  [60]	  indicated	  that	  TLR4	  
stimulation	  decreased	  intestinal	  proliferation.	  In	  contrast,	  Santaolalla	  et	  al.	  (2013)	  
reported	  that	  TLR4	  activation	  increased	  proliferation	  of	  intestinal	  stem	  cells.	  This	  
previous	  research	  however,	  was	  carried	  out	  using	  the	  mouse	  small	  intestine,	  so	  
results	  may	  differ	  in	  the	  human	  colon.	  
With	  this	  prior	  knowledge,	  I	  aimed	  to	  investigate	  the	  regulation	  of	  
proliferation	  of	  the	  colonic	  epithelium	  by	  using	  a	  human	  colonic	  organoid	  model,	  
to	  quantify	  how	  proliferation	  changes	  when	  the	  organoid	  cultures	  were	  
chronically	  exposed	  to	  physiological	  concentrations	  of	  bacterial	  components	  
including	  LPS,	  LTA,	  Flagellin	  and	  MDP. 
The	  model	  being	  used	  stimulates	  the	  basolateral	  PRRs.	  As	  mentioned	  
earlier,	  the	  luminal	  side	  of	  the	  epithelium	  is	  constantly	  exposed	  to	  higher	  
concentrations	  of	  microbial	  antigens,	  unlike	  the	  serosal	  side.	  This	  means	  that	  PRR	  
activation	  on	  the	  serosal	  side	  of	  the	  stem	  and	  TA	  cells	  provides	  a	  mechanism	  to	  
regulate	  proliferation	  and	  allow	  the	  cells	  to	  respond	  to	  changes	  in	  the	  efficacy	  of	  
the	  barrier,	  as	  recognised	  by	  changes	  in	  serosal	  microbial	  concentrations.	  	  
It	  was	  hypothesised	  that	  exposing	  the	  enteroids	  to	  bacterial	  components	  
would	  increase	  stem	  cell	  proliferation.	  The	  rational	  behind	  this	  is	  that	  activating	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the	  basolateral	  membrane	  receptors	  would	  replicate	  a	  situation	  were	  microbes	  
were	  able	  to	  breach	  the	  epithelial	  barrier	  and	  pass	  into	  the	  lamina	  propria.	  Any	  
microbe,	  regardless	  of	  whether	  it	  is	  pathogenic	  or	  commensal	  in	  the	  lumen	  is	  
considered	  pathogenic	  by	  the	  body	  when	  it	  is	  found	  within	  the	  lamina	  propria.	  In	  
this	  location,	  it	  is	  able	  to	  activate	  immune	  cells	  and	  cause	  inflammation	  via	  
interactions	  with	  immune	  cell	  PRRs.	  Microbes	  can	  also	  interact	  with	  PRRs	  on	  the	  
epithelial	  cells,	  which	  would	  cause	  the	  epithelium	  to	  respond	  and	  potentially	  
modulate	  proliferation.	  The	  reason	  it	  was	  hypothesised	  that	  proliferation	  would	  
increase,	  was	  because	  microbes	  in	  the	  lamina	  propria	  would	  indicate	  damage	  to	  
the	  barrier,	  so	  rapid	  regeneration	  and	  repair	  of	  the	  epithelium,	  driven	  by	  
increased	  proliferation	  would	  prevent	  further	  bacteria	  from	  passing	  into	  the	  
lamina	  propria	  and	  therefore	  inducing	  an	  increased	  immune	  response.	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2 Methods	  
2.1 Patient	  samples	  
Patients	  for	  this	  study	  were	  recruited	  from	  the	  Dunedin	  Public	  Hospital	  
and	  were	  undergoing	  routine	  colonoscopies	  or	  bowel	  resections.	  These	  patients	  
were	  termed	  control	  patients,	  and	  had	  not	  been	  diagnosed	  with	  inflammatory	  
bowel	  disease	  (IBD).	  From	  these	  patients,	  two	  different	  sample	  types	  were	  
received.	  The	  first	  were	  termed	  “large	  samples”,	  which	  were	  2x2	  cm	  of	  
macroscopically	  normal	  sections	  of	  transverse	  colon	  and	  were	  from	  patients	  
having	  bowel	  resections.	  All	  other	  samples	  were	  biopsy	  samples	  of	  normal	  
transverse	  colon	  tissue	  collected	  with	  “jumbo”	  forceps	  (3x3	  mm).	  	  
2.2 Ethics	  
All	  work	  was	  approved	  by	  the	  Health	  and	  Disability	  Ethics	  Committee	  
(Ethics	  number	  13/STH/155)	  to	  allow	  the	  collection	  and	  long-­‐term	  culture	  of	  
human	  colonic	  stem	  cells.	  	  
2.3 Sample	  preparation	  
Samples	  were	  collected	  in	  pottles	  containing	  advanced	  DMEM/F12	  (Life	  
Technologies,	  USA),	  and	  antibiotics	  including	  1%	  Penicillin	  Streptomycin	  
(Pen/Strep,	  Life	  Technologies,	  USA),	  gentamycin	  (50	  µg/ml,	  Life	  Technologies,	  
USA),	  fungizone	  (2.5	  µg/ml	  Life	  Technologies,	  USA),	  normocin	  (0.1	  mg/ml,	  
Integrated	  Science,	  Australia)	  and	  5	  %	  Foetal	  Bovine	  Serum	  (FBS,	  Life	  
Technologies,	  USA).	  For	  large	  samples,	  under	  sterile	  conditions,	  the	  piece	  of	  tissue	  
was	  washed	  4	  times	  in	  PBS	  +	  2	  %	  Pen/Strep	  +	  fungizone	  (5	  µg/ml)	  +	  5	  %	  FBS	  to	  
remove	  faecal	  material.	  The	  tissue	  was	  then	  transferred	  to	  a	  petri	  dish,	  where	  the	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underlying	  muscle	  layer	  was	  removed	  by	  blunt	  dissection	  and	  the	  tissue	  cut	  into	  
smaller	  pieces.	  Each	  piece	  was	  then	  placed	  into	  a	  separate	  15	  ml	  tube	  and	  
subsequently	  treated	  the	  same	  as	  the	  biopsy	  samples.	  For	  biopsy	  samples,	  under	  
sterile	  conditions,	  the	  collection	  media	  was	  removed.	  Both	  samples	  were	  then	  
placed	  in	  10	  mM	  dithiothreitol	  in	  phosphate	  buffered	  saline	  (DTT	  (Sigma,	  
USA)/PBS	  (Life	  Technologies)	  in	  a	  15	  ml	  tube.	  The	  samples	  were	  then	  washed	  by	  
rolling,	  followed	  by	  incubation	  in	  8	  mM	  Ethylenediaminetetraacetic	  acid	  in	  PBS 
(EDTA/PBS,	  pH	  7.5)	  on	  ice	  for	  60	  min.	  The	  EDTA	  was	  then	  replaced	  with	  PBS	  and	  
the	  sample	  shaken.	  The	  crypt-­‐enriched	  supernatant	  was	  transferred	  to	  a	  50	  ml	  
tube	  and	  FBS	  added	  to	  a	  final	  concentration	  of	  5	  %.	  This	  was	  repeated	  until	  all	  
crypts	  were	  removed	  and	  the	  supernatant	  was	  clear.	  The	  tube	  was	  spun	  at	  40	  x	  g	  
for	  2	  min	  at	  4	  °C	  (Hereus	  centrifuge,	  Thermo	  Scientific,	  USA),	  the	  supernatant	  
removed	  and	  the	  pellet	  resuspended	  in	  5	  ml	  DMEM/F12	  +5	  %	  FBS	  +	  antibiotics	  
(as	  above),	  and	  spun	  again	  at	  40	  x	  g	  for	  2	  min.	  This	  was	  repeated	  and	  the	  pellet	  
resuspended	  in	  1	  ml	  DMEM/F12	  +5	  %	  FBS	  +	  antibiotics	  in	  a	  1.5	  ml	  tube.	  This	  was	  
spun	  at	  0.1	  relative	  centrifugal	  force (rcf)	  for	  2	  min	  at	  room	  temperature	  and	  the	  
supernatant	  was	  removed.	  The	  crypts	  were	  then	  resuspended	  in	  Matrigel®	  (in	  
Vitro	  Technologies,	  NZ)	  (50	  μl	  per	  well)	  and	  1-­‐2	  drops	  of	  the	  mixture	  was	  added	  to	  
each	  well	  of	  a	  24	  well	  plate	  (ThermoFisher,	  USA).	  This	  was	  incubated	  at	  37	  °C	  for	  
10	  min	  to	  polymerise	  the	  Matrigel®	  before	  being	  overlayed	  with	  500µl	  37	  °C	  
culture	  media	  (Table	  2.1)	  before	  being	  returned	  to	  a	  37	  °C	  incubator.	  
2.4 Organoid	  culture	  
The	  protocol	  used	  for	  organoid	  culture,	  was	  adapted	  from	  that	  described	  
by	  Sato	  et	  al.,	  (2011,	  ).	  Organoid	  culture	  media	  was	  prepared	  in	  25-­‐50	  ml	  aliquots	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as	  required.	  It	  contained	  growth	  additives	  and	  antibiotics	  as	  listed	  in	  Table	  2.1.	  
The	  culture	  media	  was	  stored	  at	  4	  °C	  and	  heated	  to	  37	  °C	  in	  a	  water	  bath	  before	  
use.	  The	  culture	  media	  was	  changed	  every	  2-­‐3	  d	  by	  removing	  the	  current	  500	  µl	  of	  
media	  and	  replacing	  it	  with	  500	  µl	  of	  fresh,	  warmed	  media.	  	  
Table	  2.1:	  Additives	  included	  in	  the	  organoid	  growth	  media	  
A	  list	  of	  the	  growth	  additives	  used	  in	  the	  organoid	  culture	  media,	  which	  were	  included	  to	  maintain	  
the	  stem	  cell	  niche.	  The	  final	  concentration	  of	  each	  additive,	  along	  with	  the	  supplier	  is	  listed	  
Additive	   Final	  concentration	   Supplier	  
N2	  supplement	   1	  X	   Life	  Technologies,	  USA	  
B27	  supplement	   1	  X	   Life	  Technologies,	  USA	  
Nicotinamide	   10	  mM	   Sigma,	  USA	  
N-­‐acetyl-­‐L-­‐cysteine	   1	  mM	   Sigma,	  USA	  
LY	  2157299	   500	  nM	   AxonMedChem,	  USA	  
SB	  202190	   10	  µM	   Sigma,	  USA	  
Prostaglandin	  E2	   0.01	  µM	   Sigma,	  USA	  
Human	  Epidermal	  growth	  factor	   50	  ng/ml	   Life	  Technologies,	  USA	  
Noggin	   100	  ng/ml	   PeproTech,	  USA	  
Gastrin	   1	  µg/ml	   Pharmaco,	  USA	  
Advanced	  DMEM/F12	   	  to	  make	  to	  final	  volume	   Life	  Technologies,	  USA	  
Glutamax	   1	  X	   Life	  Technologies,	  USA	  
Hepes	   10	  mM	   Sigma,	  USA	  
Pen/Strep	   1	  %	   Life	  Technologies,	  USA	  
Normocin	   0.1	  mg/ml	   Integrated	  Science,	  
Australia	  Gentamycin	   50	  µg/ml	   Life	  Technologies,	  USA	  
Wnt3A	  media	   50	  %	   Conditioned	  media	  
R-­‐spondin	  media	   10	  %	   Conditioned	  media	  
	  
Unless	  the	  organoids	  were	  being	  used	  for	  an	  experiment,	  they	  were	  
passaged	  (mechanical	  disruption)	  every	  5-­‐7	  d.	  This	  involved	  removing	  the	  media	  
from	  the	  wells	  and	  washing	  the	  Matrigel®/organoids	  with	  500	  µl	  of	  ice	  cold	  PBS	  
per	  well.	  This	  was	  removed	  and	  another	  500	  µl	  of	  ice	  cold	  PBS	  was	  added	  per	  
sample	  and	  the	  Matrigel®/organoids	  were	  transferred	  to	  a	  1.5	  ml	  tube.	  Each	  well	  
was	  washed	  with	  another	  500	  µl	  of	  ice	  cold	  PBS	  which	  was	  also	  added	  to	  the	  tube.	  
Each	  samples	  tube	  was	  incubated	  on	  ice	  for	  30+	  min	  to	  dissolve	  the	  Matrigel®	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before	  being	  spun	  in	  a	  microfuge	  at	  900	  x	  g	  for	  2.5	  min	  at	  4	  °C	  (Eppendorf,	  USA).	  
The	  supernatant	  was	  removed,	  and	  the	  loose	  pellet	  resuspended	  in	  ice	  cold	  PBS	  to	  
the	  final	  volume	  of	  1000	  µl.	  The	  organoids	  were	  disrupted	  by	  being	  passed	  
through	  a	  25-­‐gauge	  needle	  (Terumo,	  Phillipines)	  6	  or	  more	  times.	  The	  tube	  was	  
centrifuged	  at	  900	  x	  g	  for	  2.5	  min	  at	  4	  °C	  to	  pellet	  the	  cells	  and	  the	  supernatant	  
was	  removed	  leaving	  the	  organoid	  pellet.	  This	  was	  resuspended	  in	  ice-­‐cold	  
Matrigel®	  (50	  µl	  per	  well)	  and	  1-­‐2	  drops	  of	  the	  Matrigel®/cells	  were	  added	  to	  each	  
well	  on	  a	  24	  well	  plate	  (pre	  warmed	  to	  37	  °C).	  The	  plate	  was	  incubated	  at	  37	  °C	  for	  
10	  min	  to	  polymerise	  the	  Matrigel®,	  before	  500	  µl	  of	  culture	  media	  plus	  ROCK	  
inhibitor	  Y	  -­‐27623	  (final	  concentration	  10	  µM,	  Merek	  Milipore,	  USA)	  was	  added	  to	  
each	  well.	  ROCK	  inhibitor	  was	  included	  in	  the	  media	  to	  help	  the	  organoids	  reform,	  
by	  inhibiting	  apoptosis	  [85].	  Media	  containing	  ROCK	  was	  left	  in	  the	  cultures	  for	  2	  
d,	  before	  being	  replaced	  with	  normal	  media,	  which	  was	  changed	  every	  2-­‐3	  d.	  	  
When	  growing	  the	  organoids,	  a	  number	  of	  morphologies	  were	  present.	  At	  
4	  d	  post	  passage,	  the	  majority	  of	  the	  organoids	  were	  thin	  walled,	  translucent	  
structures	  names	  spheroids	  (Fig.	  2.1).	  As	  the	  cultures	  grew,	  round	  structures	  with	  
a	  thicker,	  more	  defined	  membrane	  developed,	  termed	  thick	  walled	  spheroids	  (Fig.	  
2.1).	  Finally,	  convoluted	  structures,	  with	  an	  opaque	  appearance	  and	  well-­‐defined	  
membrane	  formed,	  with	  increasing	  numbers	  at	  15	  d	  compared	  with	  4	  d	  (Gadeock	  
and	  Butt,	  pers	  comm).	  These	  structures	  were	  termed	  enteroids,	  and	  consisted	  of	  a	  
single	  layer	  of	  epithelial	  cells	  that	  resembles	  the	  epithelium	  seen	  in	  the	  colon	  (Fig.	  
2.1).	  	  
	  24	  
	  
Figure	  2.1:	  Organoid	  Morphologies	  
Representative	  image	  of	  the	  different	  phenotypes	  seen	  when	  growing	  organoid	  cultures.	  a)	  Light	  
microscope	  images	  of	  a	  thin	  walled	  spheroid,	  a	  thick	  walled	  spheroid	  and	  a	  convoluted	  enteroid	  (L-­‐
R),	  as	  indicated	  on	  the	  images,	  all	  taken	  at	  4x	  magnification.	  b)	  Transmission	  electron	  micrograph	  
images	  of	  the	  enteroid	  and	  spheroid	  epithelium	  (L-­‐R)	  as	  indicated	  on	  the	  images.	  These	  show	  the	  
difference	  in	  maturation	  between	  the	  two	  phenotypes.	  Scale	  bar	  on	  the	  left	  hand	  image	  =	  10	  μm,	  
scale	  bar	  on	  the	  right	  hand	  image	  =	  5	  μm.	  TEM	  images	  provided	  by	  Gadeock	  and	  Butt	  (pers	  comm).	  
2.4.1 Experimental	  protocol	  for	  organoids	  
To	  carry	  out	  an	  experiment,	  all	  of	  the	  organoids	  from	  one	  patient	  were	  
pooled	  and	  passaged	  into	  the	  required	  number	  of	  wells	  on	  a	  24	  well	  plate	  (Fig.	  
2.2).	  For	  whole	  mount	  imaging	  experiments,	  the	  organoids	  were	  plated	  onto	  
coverslips	  placed	  at	  the	  bottom	  of	  the	  wells	  in	  the	  plate.	  After	  2d,	  the	  media	  was	  
replaced	  with	  fresh	  media	  without	  ROCK	  inhibitor.	  Four	  days	  post	  passage,	  the	  
media	  was	  changed	  for	  experimental	  media	  with	  either	  growth	  factors	  removed,	  
N-­‐[(3,5-­‐Difluorophenyl)acetyl]-­‐L-­‐alanyl-­‐2-­‐phenyl]glycine-­‐1,1-­‐dimethylethyl	  ester	  
(DAPT,	  Tocris,	  UK	  )	  or	  bacterial	  components	  added,	  as	  listed	  in	  Table	  2.2.	  The	  
organoids	  were	  grown	  under	  these	  conditions	  for	  a	  further	  10	  d,	  with	  media	  
changes	  every	  2-­‐3	  d.	  The	  organoids	  were	  then	  harvested	  for	  experimental	  
protocols	  to	  be	  performed	  at	  15	  d	  of	  growth.	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Figure	  2.2:	  Experimental	  design	  
A	  representative	  image	  to	  show	  how	  organoids	  are	  pooled	  together	  at	  passage,	  and	  split	  into	  a	  
number	  of	  wells	  on	  the	  same	  plate	  for	  an	  experiment.	  
	  
Table	  2.2:	  Experimental	  conditions	  for	  organoid	  growth	  
Added	  4	  d	  post	  passage	  for	  10	  d	  
Condition	   Concentration	   Source	   Supplier	  
Removal	  of	  growth	  
factors	  
	   	   	  
Minus	  Wnt3A	  from	  normal	  
media	  (replaced	  with	  
DMEM	  F12)	  
0	  %	   n/a	   Conditioned	  
media	  
Minus	  LY2157299	  and	  
SB202190	  from	  normal	  
media	  (replaced	  with	  
DMEM	  F12)	  
0	  %	   n/a	   Conditioned	  
media	  
Addition	  of	  DAPT	   	   	   	  
+DAPT	   10	  μM	   n/a	   Tocris,	  UK	  
Addition	  of	  bacterial	  
components	  
	   	   	  
+LPS	   20	  ng/ml	   E.	  coli	   InvivoGen,	  USA	  
+Flagellin	   20	  ng/ml	   S.	  
typhimurium	  
Sigma-­‐Aldrich,	  
USA	  
+LTA	   20	  ng/ml	   S.	  aureus	   InvivoGen,	  USA	  
+MDP	   20	  ng/ml	   Synthetic	   Sigma	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2.5 Cell	  culture	  –	  Caco-­‐2	  cells	  
Colorectal	  adenoma	  carcinoma	  cells	  (Caco-­‐2	  cells)	  were	  used	  to	  test	  
imaging	  kits	  and	  optimise	  protocols	  before	  use	  on	  organoids.	  The	  cells	  were	  
grown	  in	  25	  ml	  flasks	  (in	  Vitro	  Technologies,	  USA)	  and	  every	  2	  d,	  the	  media	  was	  
removed	  and	  replaced	  with	  5	  ml	  of	  fresh	  media	  pre	  heated	  to	  37	  °C.	  Caco-­‐2	  cell	  
media	  was	  made	  up	  of	  DMEM+10	  %	  FCS	  (Life	  Technologies,	  USA).	  Every	  3-­‐4	  d,	  
when	  the	  cells	  were	  ≈80	  %	  confluent	  they	  were	  passaged.	  This	  involved	  removing	  
the	  culture	  media	  and	  washing	  the	  cells	  twice	  with	  warm	  (37	  °C)	  PBS.	  3	  ml	  
Trypsin	  (Thermofisher,	  USA)	  was	  then	  added	  to	  the	  flask	  for	  10-­‐15	  min	  at	  37	  °C	  
before	  quenching	  the	  reaction	  with	  warm	  media.	  This	  was	  removed	  from	  the	  flask	  
and	  placed	  in	  a	  15	  ml	  tube.	  The	  flask	  was	  washed	  with	  warm	  media,	  which	  was	  
also	  added	  to	  the	  tube.	  The	  cells	  were	  spun	  for	  3	  min	  at	  3	  rcf	  to	  pellet	  the	  cells	  	  
(Eppendorf	  Centrifuge,	  USA).	  The	  supernatant	  was	  removed	  and	  the	  pellet	  
resuspended	  in	  an	  appropriate	  volume	  of	  media.	  For	  experiments,	  cells	  were	  
seeded	  into	  24	  well	  plates	  at	  a	  density	  of	  4x104	  per	  well.	  For	  maintaining	  the	  
culture,	  a	  small	  volume	  of	  the	  cells	  was	  removed	  and	  transferred	  to	  a	  new	  25	  ml	  
flask,	  with	  additional	  media	  added	  to	  dilute	  the	  cells,	  and	  the	  total	  volume	  made	  
up	  to	  5	  ml.	  The	  media	  was	  then	  changed	  every	  2-­‐3	  d.	  	  
2.6 Quantitative	  polymerase	  chain	  reaction	  (qPCR)	  
2.6.1 RNA	  Isolation	  
To	  isolate	  RNA	  from	  the	  organoids,	  the	  enteroids	  were	  collected	  from	  the	  
Matrigel®	  using	  a	  1	  ml	  16-­‐gauge	  needle	  under	  a	  light	  microscope,	  based	  on	  their	  
morphological	  appearance,	  and	  placed	  into	  a	  1.5	  ml	  tube.	  These	  were	  left	  on	  ice	  
for	  30	  min	  to	  dissolve	  the	  Matrigel®,	  the	  enteroids	  centrifuged	  to	  form	  a	  pellet	  and	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the	  supernatant	  removed.	  A	  Nucleo	  spin	  miRNA	  kit,	  for	  the	  isolation	  of	  small	  and	  
large	  RNA	  (Macherey-­‐Nagel,	  Germany)	  was	  used	  following	  the	  instructions	  in	  the	  
user	  manual,	  to	  isolate	  the	  RNA	  from	  enteroid	  samples.	  Once	  the	  RNA	  was	  
extracted,	  the	  purity	  was	  measured	  with	  nuclease	  free	  water	  (Thermofisher,	  USA)	  
as	  a	  blank,	  followed	  by	  2	  μl	  of	  RNA	  from	  each	  sample.	  The	  absorbance	  of	  each	  
sample	  was	  measured	  at	  260	  nm	  and	  280	  nm	  using	  a	  spectrophotometer	  
(Synergy2,	  BioTek,	  USA),	  so	  the	  quality	  of	  the	  RNA	  could	  be	  gauged,	  and	  the	  
amount	  required	  for	  cDNA	  preparation	  could	  be	  calculated.	  	  
2.6.2 cDNA	  preparation	  
For	  all	  of	  the	  qPCR	  experiments,	  the	  cDNA	  was	  made	  to	  a	  final	  
concentration	  of	  20	  ng	  μl-­‐1.	  The	  amount	  of	  RNA	  required	  for	  this	  could	  be	  
calculated,	  or	  alternately	  11	  μl	  of	  RNA	  from	  the	  sample	  could	  be	  used,	  and	  the	  
cDNA	  diluted	  with	  nuclease	  free	  water	  to	  the	  correct	  concentration	  after	  being	  
made.	  The	  RNA	  was	  added	  to	  a	  1.5	  ml	  tube	  along	  with	  1	  μl	  of	  random	  hexamer	  
(Life	  Technologies,	  USA),	  1	  μl	  DNTP	  mix	  (Life	  Technologies,	  USA)	  and	  nuclease	  
free	  water	  (Life	  Technologies,	  USA)	  	  to	  make	  up	  the	  11	  μl	  volume,	  if	  not	  using	  the	  
full	  11	  μl	  of	  RNA.	  These	  were	  vortexed,	  centrifuged	  and	  incubated	  in	  a	  heat	  block	  
(AccuBlock,	  Labnet,	  USA)	  	  at	  65	  °C	  for	  5	  min.	  Following	  this,	  they	  were	  incubated	  
on	  ice	  for	  1	  min	  before	  a	  brief	  centrifuge.	  4	  μl	  5x	  strand	  buffer	  (Life	  Technologies,	  
USA),	  1	  μl	  0.1	  M	  DTT	  (Life	  Technologies,	  USA),	  1	  μl	  RNAse	  out	  and	  1	  μl	  super	  script	  
RTIII	  (Life	  Technologies,	  USA)	  were	  then	  added	  to	  the	  tube,	  vortexed	  and	  
centrifuged.	  The	  samples	  were	  then	  incubated	  in	  a	  heat	  block	  at	  25	  °C	  for	  5	  min,	  
50	  °C	  for	  50	  min	  and	  70	  °C	  for	  15	  min.	  The	  cDNA	  was	  then	  diluted	  to	  a	  final	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concentration	  of	  20	  ng	  μl-­‐1	  with	  nuclease	  free	  water	  and	  stored	  at	  -­‐20	  °C	  when	  not	  
in	  use.	  
2.6.3 Gene	  choice	  
Two	  main	  methods	  were	  used	  to	  identify	  suitable	  proliferation-­‐associated	  
genes	  to	  use	  for	  this	  study.	  Firstly,	  a	  literature	  search	  was	  performed,	  looking	  for	  
genes	  commonly	  used	  for	  assessing	  proliferation.	  Importantly,	  some	  papers	  
suggested	  there	  is	  a	  proliferation	  signature,	  or	  a	  number	  of	  genes	  that	  are	  
commonly	  associated	  with	  proliferation	  in	  numerous	  cells	  and	  organisms	  [65;	  88].	  
Many	  genes	  were	  common	  to	  a	  number	  of	  proliferation	  signatures	  for	  different	  
cells	  and	  species.	  The	  genes	  that	  were	  common	  between	  these	  proliferation	  
signatures	  were	  listed	  for	  further	  investigation.	  Microarray	  data	  from	  the	  
laboratory	  (Rodrigues	  and	  Butt	  pers	  comm)	  from	  control	  and	  LPS	  treated	  (20ng	  
ml-­‐1	  for	  10	  d)	  enteroids	  were	  also	  analysed	  in	  Excel.	  From	  this	  data,	  the	  genes	  
identified	  from	  the	  literature	  search	  were	  searched	  for,	  and	  those	  that	  appeared	  to	  
be	  up	  regulated	  (above	  0.5)	  or	  down	  regulated	  (below	  -­‐0.5)	  in	  LPS	  treated	  
enteroids	  compared	  with	  control	  were	  then	  selected	  to	  be	  used	  to	  investigate	  
proliferation	  in	  this	  study	  (Table	  2.3)	  .	  
Table	  2.3:	  Function	  and	  predicted	  change	  in	  proliferation-­‐associated	  genes	  used	  in	  this	  
study	  
The	  name,	  function	  in	  proliferation,	  and	  predicted	  change	  of	  the	  proliferation	  associated	  genes	  
used	  in	  this	  study.	  éindicates	  an	  increase ê	  indicates	  a	  decrease	  
Gene	   Function	   Predicted	  change	  
with	  increased	  
proliferation	  
Predicted	  change	  
with	  decreased	  
proliferation	  
Proliferating	  cell	  marker	  
Ki67	   A	  gene	  found	  in	  the	  nucleus	  of	  cells	  in	  
all	  phases	  of	  the	  cell	  cycle	  but	  is	  absent	  
from	  resting	  cells	  
é	   ê	  
Stem	  cell	  marker	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LGR5	   Common	  marker	  of	  stem	  cells	  in	  the	  
gastrointestinal	  epithelium	  and	  is	  part	  
of	  the	  Wnt	  receptor.	  
é	   ê	  
Cell	  cycle	  related-­‐positive	  effect	  
Cyclin	  D1	   Regulates	  cyclin	  dependent	  kinase	  
(cdk)	  4	  and	  6	  during	  G1	  phase	  of	  the	  
cell	  cycle.	  Its	  activation	  causes	  cdk	  
activation	  and	  therefore	  cell	  cycle	  
progression	  
é	   ê	  
FOXM1	   Regulates	  the	  expression	  of	  cyclins	  
during	  the	  S	  phase	  of	  the	  cell	  cycle.	  Its	  
activation	  allows	  cell	  cycle	  progression	  
é	   ê	  
MYC	   Drives	  cell	  proliferation	  by	  up	  
regulating	  cyclins	  and	  down	  regulating	  
cell	  cycle	  inhibitors	  
é	   ê	  
Cell	  cycle	  related-­‐negative	  effect	  
p15	   Its	  expression	  is	  induced	  by	  TGF-­‐β	  
signalling.	  It	  forms	  a	  complex	  with	  cdk	  
4	  and	  6	  to	  prevent	  progression	  through	  
the	  G1	  phase	  of	  the	  cell	  cycle	  	  
ê	   é	  
LTBP1	   Targets	  latent	  TGF-­‐β	  to	  the	  ECM	  for	  its	  
activation.	  TGF-­‐β	  activation	  is	  
associated	  with	  decreased	  
proliferation	  
ê	   é	  
	  
2.6.4 Primer	  Optimisation	  
Primers	  for	  the	  genes	  of	  interest	  were	  obtained	  from	  Integrated	  DNA	  
Technologies	  (USA)	  (Table	  2.4)	  and	  resuspended	  in	  the	  appropriate	  volume	  of	  
nuclease	  free	  water,	  depending	  on	  their	  molecular	  weight.	  qPCR	  was	  run	  in	  
triplicate	  using	  cDNA	  from	  both	  control	  crypts	  and	  total	  colon	  to	  ensure	  there	  was	  
sufficient	  expression	  of	  the	  genes	  of	  interest	  in	  the	  samples.	  The	  resultant	  
amplicon	  was	  sequenced	  (Sequencing	  Unit,	  Department	  of	  Anatomy,	  University	  
Otago,	  Dunedin)	  to	  confirm	  the	  correct	  product	  had	  been	  amplified.	  To	  optimise	  
each	  primer	  set,	  they	  were	  run	  in	  triplicate	  on	  a	  control	  crypt	  sample	  over	  a	  range	  
of	  concentrations	  along	  a	  five-­‐log	  scale	  (0.2,	  2,	  20,	  200	  ng	  μl-­‐1)	  to	  ensure	  the	  
relative	  amount	  of	  product	  was	  the	  same	  across	  the	  concentrations.	  This	  was	  then	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used	  to	  calculate	  the	  efficiency	  of	  the	  primers.	  The	  primers	  for	  Ki67,	  LGR5,	  FOXM1	  
and	  MYC,	  along	  with	  the	  housekeeping	  genes	  β-­‐actin,	  RPLPO	  and	  B2M,	  had	  
previously	  been	  optimised	  (Gadeock,	  Rodrigues	  and	  Butt,	  pers	  comm).	  Cyclin	  D,	  
p15	  and	  LTBP1	  primer	  optimisation	  was	  performed	  in	  addition,	  for	  use	  in	  this	  
study.	  Only	  primers	  with	  an	  efficiency	  of	  100%	  +/-­‐	  10%	  were	  used	  for	  subsequent	  
qPCR	  experiments	  (Table	  2.4,	  Fig.	  2.3).	  	  
Table	  2.4:	  Primers	  for	  the	  proliferation-­‐associated	  genes	  used	  in	  this	  study.	  	  
The	  sequence,	  number	  of	  base	  pairs	  and	  efficiency	  for	  the	  primer	  sets	  that	  were	  used	  in	  this	  study	  
Primer	   Sequence	   Number	  of	  
base	  pairs	  
Efficiency	  
(%)	  
Cyclin	  D1	  forward	   CTGGAGGTCTGCGAGGAACA	   25	   100.3	  
Cyclin	  D1	  reverse	   CCTTCATCTTAGAGGCCACGAA	   24	   100.3	  
p15	  forward	   AGAACAAGGGCATGCCCAGT	   20	   109	  
p15	  reverse	   ATCATCATGACCTGGATCGC	   20	   109	  
LTBP1	  forward	   GCGATGAGTTGAACAACCGGATGTC	   20	   100.4	  
LTBP1	  reverse	   TCAAGGCGGTATTCATCGGAGTGC	   22	   100.4	  
Ki67	  forward	   CTTTGGGTGCGACTTGACGA	   20	   98.2	  
Ki67	  reverse	   GGCCAGAAGCAAATTTACAAC	   21	   98.2	  
LGR5	  forward	   TCACCTTCCCCAGGCCCCTT	   20	   97.3	  
LGR5	  reverse	   CGCATCCACACCAGCCAGCA	   20	   97.3	  
FOXM1	  forward	   AGGGTGGTCCGTGTAAAT	   18	   102.1	  
FOXM1	  reverse	   ACCTCAGCCTGGAAGAAA	   18	   102.1	  
MYC	  forward	   GCTGCTTAGACGCTGGATTT	   20	   101	  
MYC	  reverse	   CACCGAGTCGTAGTCGAGGT	   20	   101	  
β-­‐actin	  forward	   AGCACGGCATCGTCACCAACT	   21	   96	  
β-­‐actin	  reverse	   TGGCTGGGGTGTTGAAGGTCT	   21	   96	  
RPLPo	  forward	   GCAATGTTGCCAGTGTCTG	   19	   98.9	  
RPLPo	  reverse	   GCCTTGACCTTTTCAGCAA	   19	   98.9	  
β2M	  forward	   GCGCTACTCTCTCTTTCTGG	   20	   100.9	  
β2M	  reverse	   GCTGGATGACGTGAGTAAAC	   21	   100.9	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Figure	  2.3:	  Primer	  efficiency	  graphs	  
The	  efficiency	  for	  the	  primers	  Cyclin	  D1,	  p15	  and	  LTBP1	  across	  a	  Log	  dilution	  scale.	  All	  primers	  had	  
an	  efficiency	  of	  100	  +/-­‐10%	  	  
2.6.5 qPCR	  experimental	  set	  up	  
For	  each	  qPCR	  measurement,	  a	  treatment	  and	  control	  of	  the	  same	  passage	  
number	  from	  each	  patient	  was	  run	  in	  triplicate	  for	  each	  gene	  of	  interest,	  along	  
with	  the	  housekeeping	  genes	  β-­‐actin,	  β2M	  and	  RPLPo	  (Integrated	  DNA	  
Technologies,	  USA)	  as	  endogenous	  controls	  (Fig.	  2.4).	  They	  were	  chosen	  as	  
endogenous	  controls	  as	  their	  levels	  of	  transcript	  remain	  constant	  in	  both	  controls	  
and	  under	  experimental	  conditions.	  All	  reactions	  consisted	  of	  8	  μl	  of	  master	  mix	  
and	  2	  μl	  of	  cDNA	  from	  each	  sample	  per	  well.	  The	  master	  mix	  included	  5.2	  μl	  SYBR	  
Green	  (Medi’ray,	  NZ),	  0.2	  μl	  of	  the	  relevant	  forward	  primer,	  0.2	  μl	  of	  the	  relevant	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reverse	  primer	  and	  2.4	  μl	  of	  nuclease	  free	  water	  per	  well.	  The	  master	  mix	  was	  
prepared	  by	  hand,	  and	  8	  μl	  of	  master	  mix,	  along	  with	  2	  μl	  of	  the	  appropriate	  cDNA	  
was	  pipetted	  into	  the	  appropriate	  wells	  of	  a	  96	  well	  plate	  (Biorad,	  USA)	  and	  sealed	  
with	  an	  adhesive	  seal	  (Biorad,	  USA).	  A	  CFX	  connect	  Real-­‐Time	  system	  (Biorad,	  
USA)	  was	  used	  for	  all	  of	  the	  qPCR	  measurements,	  following	  the	  acquisition	  
protocol	  in	  Table	  2.5.	  Subsequent	  analysis	  to	  normalise	  the	  data	  to	  the	  
endogenous	  controls	  was	  performed	  in	  Excel,	  followed	  by	  graphing	  and	  analysis	  of	  
statistical	  significance	  in	  Prism	  6	  (GraphPad	  software,	  USA).	  
	  
Figure	  2.4:	  Experimental	  set	  up	  of	  a	  qPCR	  plate	  
Representative	  image	  of	  how	  control	  and	  treated	  enteroid	  samples	  were	  set	  up	  in	  triplicate	  for	  
qPCR	  experiments	  
Table	  2.5:	  qPCR	  melt	  curve	  protocol	  
The	  steps	  that	  were	  followed	  during	  each	  qPCR	  experimental	  protocol	  including	  the	  temperature	  
and	  time	  for	  each	  step,	  to	  produce	  the	  melt	  curves	  for	  analysis	  
Step	   Temperature	  (°C)	   Time	  (s)	  
1	   95	   30	  
2	   95	   5	  
3	   60	   30	  
4	   Repeat	  steps	  2-­‐3	   40	  times	  
5	   60	   30	  
6	   65	   5	  
7	   95	   5	  
END	   	   	  
	  
2.7 Flow	  cytometry	  
Flow	  cytometry	  was	  initially	  performed	  on	  Caco-­‐2	  cells	  stained	  with	  the	  
Click-­‐iT®	  Plus	  EdU	  Alexa	  Fluor®	  488	  Imaging	  Kit	  (Life	  technologies,	  USA)	  to	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optimise	  the	  technique.	  Unstained	  organoids	  were	  also	  initially	  used	  to	  ensure	  
they	  could	  be	  run	  through	  the	  flow	  cytometer	  before	  also	  being	  stained	  with	  the	  
EdU	  kit.	  
2.7.1 Caco-­‐2	  cell	  flow	  cytometry	  protocol	  
Caco-­‐2	  cells	  were	  cultured	  in	  flasks	  as	  previously	  described,	  before	  being	  
seeded	  into	  4	  wells	  in	  a	  24	  well	  plate	  and	  allowed	  to	  grow	  for	  2	  d	  before	  flow	  
cytometry	  analysis.	  The	  EdU	  component	  of	  the	  Click-­‐iT®	  Plus	  EdU	  Alexa	  Fluor®	  
488	  Imaging	  Kit	  (Life	  technologies,	  USA)	  was	  added	  to	  two	  wells	  of	  cells,	  as	  per	  the	  
manufacture’s	  instruction,	  for	  the	  final	  2	  h	  of	  growth,	  at	  a	  final	  concentration	  of	  10	  
µM.	  
The	  cells	  were	  then	  incubated	  in	  trypsin	  for	  10-­‐15	  min	  at	  37	  °C	  to	  remove	  
them	  from	  the	  plate	  and	  ensure	  that	  they	  were	  separated	  into	  single	  cells,	  before	  
stopping	  the	  reaction	  with	  Caco-­‐2	  media.	  The	  cells	  were	  spun	  at	  3	  x	  g	  for	  5	  min,	  
the	  supernatant	  removed	  and	  the	  pellet	  resuspended	  in	  500	  μl	  of	  1	  %	  bovine	  
serum	  albumin	  (BSA)	  in	  PBS.	  This	  was	  repeated,	  followed	  by	  resuspending	  the	  
pellet	  in	  500	  μl	  4	  %	  paraformaldehyde	  (PFA)	  and	  incubating	  at	  room	  temperature	  
for	  15	  min.	  Another	  wash	  in	  1	  %	  BSA	  in	  PBS	  was	  done,	  the	  supernatant	  removed	  
and	  the	  pellet	  resuspended	  in	  100	  μl	  0.1	  %	  saponin	  in	  1	  %	  BSA	  in	  PBS	  
(permeabilisation	  solution)	  and	  allowed	  to	  incubate	  for	  15	  min	  at	  room	  
temperature.	  	  
The	  tubes	  containing	  cells	  obtained	  from	  each	  of	  the	  4	  wells	  were	  then	  
processed	  as	  follows.	  Two	  tubes,	  which	  had	  been	  incubated	  with	  EdU	  for	  2	  h	  prior	  
to	  fixation	  were	  stained	  by	  adding	  500	  μl	  of	  the	  EdU	  Reaction	  cocktail	  (Alexa	  Fluor	  
detection	  method),	  made	  as	  per	  the	  manufacture’s	  instructions	  to	  each	  tube,	  and	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incubated	  in	  the	  dark	  for	  30	  min	  (Fig.	  2.5)	  One	  of	  the	  EdU	  stained	  tubes,	  along	  
with	  another	  tube	  of	  cells	  not	  incubated	  with	  EdU,	  were	  stained	  with	  Zombie	  
Violet™	  Fixable	  Viability	  Kit (BioLegend,	  USA)	  (Fig.	  2.5).	  The	  dye	  was	  added	  at	  a	  
1:100	  dilution	  to	  the	  cells	  in	  PBS	  and	  incubated	  for	  30	  min	  in	  the	  dark.	  A	  final	  tube	  
of	  cells	  that	  had	  not	  been	  incubated	  with	  EdU	  prior	  to	  fixation	  was	  also	  stained	  
with	  the	  EdU	  secondary	  reaction	  cocktail	  as	  an	  unstained	  control	  (Fig.	  2.5).	  The	  
cells	  were	  then	  pelleted,	  washed	  with	  permeabilisation	  solution,	  centrifuged,	  and	  
the	  subsequent	  pellet	  resuspended	  in	  500	  μl	  permeabilisation	  solution.	   
These	  were	  then	  run	  through	  the	  Gallios	  (Beckman	  Coulter,	  USA)	  flow	  
cytometry	  machine	  to	  set	  gates	  and	  acquire	  data	  on	  the	  number	  of	  EdU	  positive	  
proliferating	  nuclei.	  Kaluza	  software	  (Beckman	  Coulter,	  USA)	  was	  used	  during	  
acquisition.	  Analysis	  including	  setting	  gates	  and	  generating	  histograms	  was	  
performed	  using	  FlowJo	  (FlowJo	  LLC,	  USA)	  software.	  
	  
Figure	  2.5:	  Protocol	  used	  for	  Caco-­‐2	  flow	  cytometry	  staining	  
Representative	  image	  of	  the	  incubation	  and	  staining	  of	  Caco-­‐2	  cells	  used	  for	  flow	  cytometry	  
experiments	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2.7.2 Organoid	  flow	  cytometry	  protocol	  
The	  organoids	  were	  grown	  as	  per	  the	  culture	  methods	  described	  above,	  
for	  4	  d,	  followed	  by	  a	  further	  10	  d	  of	  experimental	  conditions.	  The	  recommended	  
time	  for	  EdU	  incubation	  was	  2	  h	  for	  cell	  lines,	  so	  this,	  along	  with	  4,	  6	  and	  16	  h	  
were	  tested	  to	  see	  which	  gave	  the	  best	  staining.	  It	  was	  found	  that	  incubation	  with	  
EdU,	  by	  adding	  it	  to	  the	  appropriate	  wells	  as	  per	  the	  manufacture’s	  instructions,	  
for	  16	  h	  prior	  to	  fixation	  was	  the	  best	  time	  point	  to	  get	  sufficient	  staining.	  For	  each	  
flow	  cytometry	  experiment,	  8	  wells	  of	  organoids	  were	  grown	  on	  a	  24	  well	  plate;	  2	  
wells	  for	  each	  required	  control,	  treatment	  or	  stain,	  which	  were	  pooled	  together	  to	  
ensure	  reasonable	  cell	  numbers.	  	  
On	  day	  15	  after	  incubation	  with	  EdU,	  the	  enteroids	  and	  spheroids	  were	  
collected	  and	  placed	  into	  different	  1.5	  ml	  tubes.	  The	  tubes	  were	  then	  incubated	  on	  
ice	  for	  30	  min	  to	  dissolve	  the	  Matrigel®.	  The	  organoids	  were	  then	  centrifuged	  at	  
900	  x	  g	  for	  2.5	  min,	  the	  supernatant	  removed	  and	  the	  pellet	  resuspended	  in	  PBS.	  
This	  was	  again	  centrifuged,	  and	  the	  supernatant	  removed,	  before	  incubation	  with	  
trypsin	  for	  15	  min	  at	  37	  °C.	  The	  organoids	  were	  further	  sheared	  with	  a	  1	  ml	  25-­‐
gauge	  needle	  2-­‐3	  times	  to	  ensure	  they	  were	  broken	  into	  single	  cells.	  The	  same	  
washing,	  fixing,	  permeabilisation	  and	  secondary	  detection	  methods	  were	  then	  
carried	  out	  as	  described	  for	  the	  Caco-­‐2	  cells.	  	  
A	  total	  of	  8	  tubes	  were	  used	  for	  organoid	  experiments,	  one	  each	  for	  
unstained	  control	  (which	  had	  not	  been	  incubated	  with	  EdU	  prior	  to	  fixation),	  EdU	  
only	  stained,	  Zombie	  Violet™	  only	  stained	  and	  Zombie	  Violet™	  and	  EdU	  double	  
stained	  for	  both	  the	  enteroids	  and	  the	  spheroids	  (Fig.	  2.6).	  If	  LPS	  treated	  enteroids	  
and	  spheroids	  were	  tested,	  a	  further	  2	  wells	  were	  set	  up	  and	  grown	  for	  4	  d	  under	  
normal	  conditions,	  and	  10	  d	  in	  the	  presence	  of	  LPS	  (20	  ng	  mL-­‐1),	  and	  processed	  in	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the	  same	  manner	  as	  the	  EdU	  and	  Zombie	  Violet™	  double	  stained	  cells.	  They	  were	  
then	  analysed	  in	  the	  same	  manner	  as	  the	  Caco-­‐2	  cells.	  
	  
Figure	  2.6:	  Protocol	  used	  for	  organoid	  flow	  cytometry	  staining	  
The	  incubation,	  splitting	  and	  staining	  of	  both	  enteroids	  and	  spheroids	  performed	  for	  flow	  
cytometry	  experiments.	  A	  further	  two	  tubes,	  one	  for	  enteroids	  and	  one	  for	  spheroids,	  would	  also	  
be	  processed	  as	  for	  double	  staining	  if	  LPS	  treatment	  was	  also	  being	  investigated.	  	  
2.8 Immunohistochemistry	  using	  Ki67	  antibody	  
Organoids	  were	  grown	  as	  per	  the	  experimental	  culture	  protocol	  described	  
above.	  They	  were	  then	  removed	  from	  the	  Matrigel®	  by	  incubation	  on	  ice	  for	  30	  
min,	  washed	  in	  in	  PBS	  and	  fixed	  in	  2	  %	  paraformaldehyde	  before	  being	  embedded	  
in	  wax	  and	  sliced	  into	  5	  μm	  sections	  which	  were	  placed	  onto	  a	  glass	  microscope	  
slide.	  The	  sections	  were	  then	  rehydrated	  firstly	  with	  three	  2	  min	  xylene	  
treatments,	  followed	  by	  two	  2	  min	  treatments	  in	  absolute	  ethanol,	  one	  2	  min	  
treatment	  in	  95	  %	  ethanol	  and	  one	  1	  min	  treatment	  in	  70	  %	  ethanol	  before	  being	  
washed	  in	  water.	  Antigen	  retrieval	  steps	  were	  then	  performed.	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During	  optimisation	  of	  the	  protocol,	  both	  a	  0.01	  M	  citrate	  buffer	  and	  1	  mM	  
EDTA	  (pH	  8.0)	  were	  used	  for	  antigen	  retrieval,	  with	  the	  1	  mM	  EDTA	  solution	  
working	  better	  to	  maximize	  staining	  and	  reduce	  background.	  The	  slides	  were	  
placed	  in	  50-­‐60	  ml	  1	  mM	  EDTA	  buffer	  which	  was	  heated	  first	  for	  45	  s	  at	  100	  %	  
power	  and	  then	  10	  %	  power	  for	  12	  min	  in	  a	  microwave.	  They	  were	  left	  to	  cool	  for	  
15	  min	  at	  room	  temperature,	  before	  excess	  moisture	  was	  removed	  from	  the	  slides	  
and	  the	  organoid	  sections	  were	  outlined	  with	  a	  PAP	  pen	  (Vector,	  USA).	  
Permeabilisation	  was	  performed	  by	  incubating	  the	  sections	  in	  0.05	  %	  Triton-­‐X100	  
in	  PBS	  45	  min	  at	  room	  temperature.	  This	  was	  followed	  by	  three	  5	  min	  washes	  in	  
PBS,	  shaking	  at	  room	  temperature.	  Blocking	  steps	  were	  then	  performed.	  	  
Two	  secondary	  antibodies	  for	  Ki67	  were	  tested,	  to	  see	  which	  would	  
reduce	  background	  staining.	  The	  first	  secondary	  was	  an	  Alexaflour549	  goat	  anti	  
rabbit	  IgG	  (Invitrogen,	  USA),	  therefore	  the	  sections	  were	  blocked	  in	  5	  %	  normal	  
goat	  serum	  (NGS,	  Life	  Technologies,	  USA),	  when	  using	  this	  secondary	  antibody.	  
The	  other	  secondary	  used	  was	  a	  donkey	  anti	  rabbit	  FITC	  conjugate	  antibody	  
(Invitrogen,	  USA),	  therefore	  5	  %	  normal	  donkey	  serum	  (NDS,	  Life	  Technology,	  
USA)	  was	  used	  for	  blocking	  when	  this	  antibody	  was	  used.	  50-­‐100	  µl	  of	  the	  
appropriate	  blocking	  solution,	  diluted	  to	  5	  %	  in	  PBS	  was	  added	  to	  each	  outlined	  
section	  on	  the	  slides	  and	  incubated	  at	  room	  temperature	  in	  a	  humidified	  chamber	  
for	  2	  h.	  	  
The	  primary	  antibody	  for	  Ki67	  (Saphire	  Biosciences,	  AU)	  was	  found	  after	  
titration	  to	  work	  best	  when	  used	  at	  a	  1:50	  dilution.	  Therefore,	  it	  was	  diluted	  1:50	  
in	  the	  blocking	  buffer	  (5	  %	  NGS	  or	  NDS)	  and	  50-­‐100	  µl	  was	  added	  to	  each	  section	  
and	  incubated	  in	  a	  humidified	  chamber	  at	  4	  °C	  overnight.	  Three	  5	  min	  washes	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were	  then	  performed,	  shaking	  in	  PBS	  at	  room	  temperature.	  50-­‐100	  µl	  of	  the	  
appropriate	  secondary	  antibody,	  (1:2000	  dilution	  in	  1	  %	  blocking	  buffer),	  was	  
then	  added	  to	  each	  section	  and	  incubated	  at	  room	  temperature	  in	  the	  dark	  for	  30	  
min.	  The	  slides	  were	  washed	  twice	  for	  5	  min	  in	  the	  dark	  in	  PBS.	  100	  µl	  of	  Hoechst	  
(Invitrogen,	  USA)	  at	  1:1000	  dilution	  in	  PBS	  was	  added	  to	  each	  section	  and	  
incubated	  for	  15	  min	  at	  room	  temperature	  in	  a	  humidified	  chamber	  in	  the	  dark.	  
Three	  5	  min	  washes	  in	  PBS	  at	  room	  temperature	  shaking	  in	  the	  dark	  were	  
performed	  before	  mounting.	  	  
To	  mount,	  all	  the	  liquid	  was	  removed	  from	  the	  slide,	  a	  drop	  of	  mounting	  
solution	  (Aqua	  Polymount,	  Polysciences	  inc.,	  USA)	  was	  added	  to	  each	  section	  and	  a	  
cover	  slip	  was	  placed	  on	  top	  of	  the	  sections.	  The	  edges	  were	  then	  sealed	  with	  clear	  
nail	  polish	  and	  the	  slides	  were	  left	  in	  the	  dark	  before	  being	  imaged	  and	  
photographed	  with	  a	  confocal	  microscope	  (Zeiss	  LSM	  710,	  Germany).	  
Subsequently,	  images	  were	  viewed	  with	  Fiji	  software	  (Fiji,	  USA),	  which	  was	  used	  
to	  subtract	  background	  and	  merge	  separate	  channel	  images	  together.	  	  
2.9 Whole	  mount	  EdU	  staining	  
Whole	  mount	  organoids	  were	  stained	  with	  EdU	  for	  quantification	  of	  
proliferation.	  The	  Click-­‐iT®	  Plus	  EdU	  Alexa	  Fluor®	  488	  Imaging	  Kit	  (Life	  
technologies,	  USA)	  was	  used	  for	  this	  protocol.	  Whole	  mounts	  were	  prepared	  by	  
passaging	  organoids	  into	  the	  appropriate	  number	  of	  wells,	  on	  coverslips	  at	  the	  
bottom	  of	  the	  wells	  on	  a	  24	  well	  plate.	  They	  were	  left	  to	  grow	  for	  4	  d	  post	  passage	  
in	  normal	  media,	  before	  being	  grown	  for	  a	  further	  10	  d	  with	  experimental	  media	  
added	  to	  each	  well,	  with	  media	  changes	  every	  2-­‐3	  d	  (Fig.	  2.7).	  EdU,	  prepared	  as	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per	  the	  manufacture’s	  instructions,	  to	  a	  final	  concentration	  of	  10	  µM	  was	  added	  to	  
the	  organoid	  cultures	  and	  incubated	  for	  the	  final	  16	  h	  of	  the	  experiment.	  
	  
Figure	  2.7:	  Whole	  mount	  EdU	  imaging	  experimental	  plate	  set	  up	  
A	  representative	  image	  of	  the	  set	  up	  of	  the	  24	  well	  plate	  for	  a	  whole	  mount	  EdU	  imaging	  
experiment.	  All	  control	  and	  treatment	  wells	  were	  set	  up	  from	  the	  same	  patient	  at	  the	  same	  passage	  
number.	  
The	  Click-­‐iT®	  Plus	  EdU	  Alexa	  Fluor®	  488	  Imaging	  Kit	  (Life	  technologies,	  
USA)	  protocol	  was	  followed	  for	  fixation	  (with	  4	  %	  PFA),	  permeabilisation	  (with	  
0.5	  %	  Triton	  X-­‐100	  in	  PBS)	  and	  detection,	  with	  the	  secondary	  reaction	  cocktail	  
made	  as	  per	  the	  manufacture’s	  instructions.	  Washes	  were	  performed	  with	  3	  %	  
BSA	  in	  PBS	  or	  PBS	  as	  recommended,	  twice	  where	  required,	  each	  time	  for	  five	  
minutes.	  Nuclear	  staining	  with	  Hoechst	  was	  also	  performed	  as	  per	  the	  protocol.	  All	  
staining	  was	  performed	  in	  the	  24	  well	  plate.	  The	  coverslips	  were	  then	  removed	  
from	  the	  bottom	  of	  the	  wells	  using	  forceps	  and	  placed	  face	  down	  on	  top	  of	  
specially	  designed	  plastic	  rings	  (to	  prevent	  squashing	  the	  organoids	  and	  losing	  the	  
3-­‐D	  structure)	  which	  were	  stuck	  to	  concave	  glass	  slides.	  The	  edges	  were	  then	  
sealed	  with	  clear	  nail	  polish	  and	  the	  slides	  visualised	  using	  a	  fluorescent	  
microscope	  (Olympus	  BX51	  fluorescent	  microscope,	  USA	  and	  Nikon	  BS	  QiMC	  
camera,	  USA).	  Multiple	  images	  were	  taken	  of	  enteroids	  and	  spheroids	  from	  each	  
well,	  ensuring	  the	  whole	  organoid	  was	  imaged.	  The	  spheroid	  or	  enteroid	  
morphology	  was	  confirmed	  using	  light	  microscopy.	  Fiji	  software	  was	  used	  to	  
visualise	  the	  images,	  remove	  background,	  merge	  separate	  channel	  images	  and	  for	  
quantification.	  Quantification	  was	  done	  by	  marking	  each	  Hoechst	  stained	  nuclei	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counted,	  along	  with	  each	  EdU	  positive	  nuclei,	  in	  Fiji	  and	  counting	  with	  a	  cell	  
counter,	  to	  calculate	  a	  percentage	  of	  proliferation.	  
2.10 Statistical	  analysis	  
Due	  to	  limitations	  with	  the	  flow	  cytometry	  and	  immunohistochemistry	  
staining	  experiments,	  quantification	  was	  not	  done	  on	  these	  experiments.	  qPCR	  
data	  were	  normalised	  to	  the	  geometric	  mean	  of	  the	  housekeeping	  genes	  β-­‐actin,	  
RPLPo	  and	  β2M,	  and	  each	  treated	  sample	  was	  normalised	  to	  the	  control	  as	  a	  
hypothetical	  value	  of	  one.	  Statistical	  analysis	  for	  qPCR	  was	  performed	  using	  a	  
Student’s	  t	  test	  in	  Prism	  6	  (GraphPad	  software,	  USA)	  software.	  All	  data	  are	  shown	  
as	  the	  mean	  ±	  SEM,	  calculated	  using	  Prism	  6	  software.	  
The	  whole	  mount	  EdU	  imaging	  counts	  for	  enteroids	  and	  spheroids	  for	  
each	  patient	  were	  saved	  in	  an	  Excel	  spread	  sheet,	  and	  entered	  into	  Prism	  6	  
software	  for	  statistical	  analysis	  and	  graphing.	  The	  experiments	  where	  growth	  
factors	  were	  removed	  (minus	  Wnt3A	  and	  minus	  LY2157299	  and	  SB202190)	  and	  
the	  addition	  of	  bacterial	  components	  (LPS,	  LTA,	  flagellin	  and	  MDP)	  were	  analysed	  
using	  a	  Kruskal	  Wallis	  test	  and	  a	  Dunns	  post	  test,	  to	  compare	  each	  treatment	  to	  its	  
control	  to	  generate	  P	  values.	  For	  the	  DAPT	  treatment	  experiments,	  and	  comparing	  
control	  enteroids	  and	  spheroids,	  the	  results	  were	  analysed	  using	  a	  Mann-­‐Whitney	  
test	  to	  compare	  the	  control	  and	  treatment	  group.	  All	  data	  are	  shown	  as	  the	  mean	  ±	  
SEM,	  calculated	  using	  Prism	  6	  software.	  The	  number	  of	  repeats	  for	  experiments	  is	  
shown	  as	  n=	  number	  of	  enteroids	  or	  spheroids,	  and	  N=	  number	  of	  patients.	  
Statistical	  significance	  was	  considered	  to	  be	  P<0.05.	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3 Results	  
3.1 Preliminary	  experiments	  
There	  are	  a	  number	  of	  methods	  used	  to	  directly	  quantify	  proliferation	  in	  
cells.	  The	  first	  two	  methods	  that	  were	  used	  in	  this	  study,	  including	  flow	  cytometry	  
and	  Ki67	  immunohistochemistry,	  had	  limitations	  to	  the	  data	  generated	  for	  a	  
number	  of	  reasons.	  Due	  to	  these	  difficulties,	  and	  time	  constraints,	  other	  methods	  
were	  pursued.	  Below	  the	  results	  of	  preliminary	  experiments	  are	  shown.	  	  
3.1.1 Flow	  Cytometry	  analysis	  of	  proliferation	  
Initially	  Flow	  cytometry	  was	  attempted	  to	  quantify	  the	  proportion	  of	  
proliferating	  cells	  in	  the	  organoids.	  Due	  to	  the	  number	  of	  steps	  required	  to	  
optimise	  this	  protocol,	  and	  the	  large	  number	  of	  cells	  required,	  the	  initial	  
optimisation	  was	  carried	  out	  with	  Caco-­‐2	  cells.	  These	  have	  the	  advantage	  that	  they	  
are	  a	  fast	  growing	  culture,	  with	  a	  high	  yield	  of	  cells,	  meaning	  optimisation	  
experiments	  could	  be	  done	  with	  a	  large	  number	  of	  cells	  to	  get	  the	  most	  precise	  
results.	  	  
3.1.1.1 Flow	  cytometry	  optimisation	  for	  Caco-­‐2	  cells	  
Following	  the	  methods	  outlined	  in	  the	  previous	  chapter,	  Caco-­‐2	  cells	  were	  
seeded	  into	  a	  24	  well	  plate	  and	  left	  to	  grow	  for	  2	  days.	  Initial	  experiments	  were	  
done	  on	  unstained	  and	  live	  dead	  stained	  cells	  to	  learn	  how	  to	  use	  the	  flow	  
cytometry	  machine,	  and	  learn	  how	  to	  accurately	  set	  gates.	  The	  cells	  were	  
incubated	  with	  EdU	  for	  2	  h,	  as	  recommended,	  with	  varying	  concentrations	  tested	  
in	  an	  attempt	  to	  separate	  the	  two	  peaks,	  which	  represent	  the	  positive	  and	  negative	  
populations.	  Despite	  this,	  there	  was	  still	  problems	  with	  getting	  the	  right	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combination	  of	  the	  concentration	  of	  EdU	  incubated	  in	  the	  cells,	  along	  with	  the	  
amount	  of	  secondary	  solution	  used,	  resulting	  in	  two	  peaks	  that	  were	  not	  perfectly	  
separated.	  	  
Once	  graphed,	  a	  histogram	  showing	  the	  percentage	  of	  FL1-­‐A	  positive	  and	  
FL1-­‐A	  negative	  cells	  was	  produced.	  Caco-­‐2	  cells,	  which	  had	  not	  been	  incubated	  
with	  EdU	  prior	  to	  fixation,	  had	  a	  low	  level	  of	  FL1-­‐A	  positive	  (EdU	  positive)	  cells	  
(3.6	  %),	  which	  represents	  the	  background	  staining	  from	  the	  fluorescent	  secondary	  
solution	  (Fig.	  3.1A).	  Caco-­‐2	  cells	  which	  had	  been	  incubated	  with	  EdU	  for	  2	  h	  prior	  
to	  fixation	  were	  also	  analysed,	  and	  found	  to	  have	  68.9	  %	  of	  cells	  which	  were	  EdU	  
positive,	  indicating	  about	  69	  %	  of	  the	  cells	  in	  the	  culture	  were	  proliferating	  (Fig.	  
3.1B).	  This	  was	  expected,	  as	  the	  density	  that	  the	  cells	  were	  seeded	  at	  meant	  that	  at	  
2	  d	  growth	  they	  would	  still	  be	  sub	  confluent	  and	  therefore	  be	  rapidly	  proliferating.	  	  
	  
Figure	  3.1:	  Flow	  Cytometry	  histograms	  from	  Caco-­‐2	  cells	  	  
Histograms	  showing	  counts	  versus	  FL1-­‐A	  (EdU	  488	  laser)	  for	  Caco-­‐2	  cells.	  A)	  Unstained	  Caco-­‐2	  
cells	  B)	  EdU	  stained	  Caco-­‐2	  cells.	  Debris	  and	  doublets	  were	  gated	  out	  using	  forward	  scatter	  and	  
side	  scatter;	  dead	  cells	  were	  removed	  by	  gating	  for	  live-­‐dead	  cells	  (zombie	  violet	  dye).	  Percentages	  
of	  FL1-­‐A	  Positive	  (EdU	  positive)	  and	  FL1-­‐A	  negative	  (EdU	  negative)	  cells	  are	  shown	  on	  the	  graphs.	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3.1.1.2 Flow	  cytometry	  preliminary	  experiments	  on	  
organoids	  	  
Analysis	  was	  then	  performed	  on	  organoid	  cultures	  of	  both	  control	  and	  
LPS	  (20	  ng	  ml-­‐1	  for	  10	  d)	  treated	  enteroids	  and	  spheroids.	  Organoids	  were	  grown	  
in	  a	  24	  well	  plate,	  and	  the	  appropriate	  number	  of	  wells	  were	  incubated	  with	  EdU	  
for	  the	  final	  16	  h	  of	  growth,	  before	  being	  stained	  as	  per	  the	  methods.	  Organoids	  
treated	  with	  LPS	  were	  grown	  for	  4	  d	  post	  passage	  in	  normal	  media,	  before	  being	  
grown	  in	  experimental	  media	  for	  a	  further	  10	  d.	  They	  were	  also	  incubated	  with	  
EdU	  for	  the	  final	  16	  h	  of	  growth.	  
What	  was	  readily	  apparent	  was	  the	  lack	  of	  separation	  between	  the	  
positive	  and	  negative	  populations,	  making	  it	  difficult	  to	  correctly	  quantify	  
proliferation	  (Fig.	  3.2).	  The	  reason	  for	  this	  lack	  of	  definition	  was	  that	  it	  was	  
extremely	  difficult	  to	  get	  a	  high	  enough	  yield	  of	  cells	  from	  the	  organoid	  cultures	  to	  
be	  able	  to	  get	  precise	  results.	  For	  Caco-­‐2	  cells,	  100,000	  cells	  would	  be	  measured	  in	  
2-­‐3	  min.	  In	  contrast,	  for	  spheroids,	  3,000	  cells	  on	  average	  would	  be	  measured	  in	  5	  
min	  plus,	  and	  for	  the	  enteroids	  between	  4,000	  and	  7,000	  cells	  in	  the	  same	  time	  
span.	  Despite	  pooling	  two	  wells	  together	  from	  each	  culture	  condition	  to	  increase	  
cell	  numbers,	  they	  were	  still	  very	  low,	  making	  any	  measurements	  made	  less	  
precise.	  Due	  to	  time	  constraints,	  it	  was	  not	  feasible	  to	  grow	  extra	  wells	  to	  allow	  
pooling	  of	  3	  or	  4	  wells	  per	  condition,	  as	  organoid	  cultures	  are	  relatively	  slow	  
growing,	  so	  this	  method	  was	  no	  longer	  pursued.	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Figure	  3.2:	  Flow	  Cytometry	  histograms	  from	  organoids	  
Histograms	  showing	  counts	  versus	  FL1-­‐A	  (EdU	  488	  laser)	  for	  organoids.	  A)	  EdU	  stained	  control	  
spheroids	  B)	  EdU	  stained	  control	  enteroids	  C)	  EdU	  stained	  spheroids	  grown	  with	  the	  addition	  of	  
lipopolysaccharide	  (LPS,	  20ng	  ml-­‐1)	  for	  10	  d	  D)	  EdU	  stained	  enteroids	  grown	  with	  the	  addition	  of	  
LPS	  (20ng	  ml-­‐1)	  for	  10	  d.	  Debris	  and	  doublets	  were	  gated	  out	  using	  forward	  scatter	  and	  side	  
scatter;	  dead	  cells	  were	  removed	  by	  gating	  for	  live-­‐dead	  cells	  (zombie	  violet	  dye).	  Percentages	  of	  
FL1-­‐A	  Positive	  (EdU	  positive)	  and	  FL1-­‐A	  negative	  (EdU	  negative)	  cells	  are	  shown	  on	  the	  graphs.	  	  
3.1.2 KI67	  immunohistochemistry	  to	  assess	  organoid	  
proliferation	  
Histological	  techniques	  can	  be	  employed	  to	  quantify	  proliferation	  as	  well.	  
In	  particular	  Ki67	  staining,	  a	  marker	  of	  proliferating	  cells	  is	  a	  common	  method	  
used	  for	  this	  purpose	  [78].	  This	  was	  performed	  on	  5	  μm	  sections	  of	  organoids	  with	  
one	  of	  two	  secondary	  antibodies	  to	  firstly	  optimise	  the	  technique,	  along	  with	  a	  
nuclear	  stain	  to	  ensure	  co-­‐localisation.	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The	  first	  secondary	  antibody	  used	  had	  a	  red	  fluorescent	  tag,	  and	  was	  used	  
on	  two	  different	  patient	  samples	  (Fig.	  3.3A	  and	  Fig.	  3.3B)	  that	  were	  grown	  under	  
control	  conditions	  as	  per	  the	  methods	  and	  stained.	  Red	  arrows	  on	  the	  images	  
indicate	  representative	  examples	  of	  nuclei,	  which	  are	  positively	  stained	  for	  Ki67.	  
This	  antibody	  had	  high	  levels	  of	  background	  staining	  that	  had	  to	  be	  removed	  using	  
Fiji	  software	  once	  the	  image	  was	  taken,	  to	  better	  see	  the	  positive	  staining,	  hence	  a	  
second	  secondary	  antibody	  was	  tested	  to	  see	  if	  this	  could	  be	  improved.	  	  
	  
Figure	  3.3:	  Immunohistochemistry	  staining	  for	  proliferating	  cells	  with	  Ki67	  
Confocal	  microscope	  images	  of	  proliferating	  cells	  stained	  with	  Ki67	  (red,	  secondary	  raised	  in	  goat),	  
and	  nuclei	  stained	  with	  Hoechst	  (blue).	  A)	  and	  B)	  represent	  two	  different	  patients	  grown	  under	  
control	  conditions.	  Red	  arrows	  indicate	  an	  example	  of	  a	  Ki67	  positive	  proliferating	  cell	  
The	  second	  secondary	  antibody	  had	  a	  green	  fluorescent	  tag,	  and	  was	  used	  
to	  see	  if	  background	  staining	  could	  be	  reduced	  without	  image	  processing.	  Images	  
from	  one	  patient,	  with	  organoids	  grown	  under	  control	  conditions	  (Fig.	  3.4A)	  and	  
grown	  in	  the	  presence	  of	  LPS	  (20	  ng	  ml-­‐1)	  (Fig.	  3.4B-­‐C),	  were	  stained	  for	  Ki67.	  Red	  
arrows	  show	  representative	  Ki67	  positive	  nuclei,	  which	  represent	  proliferating	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cells.	  This	  secondary	  was	  found	  to	  have	  slightly	  better	  contrast	  between	  
background	  staining	  and	  positive	  nuclei,	  although	  it	  clung	  to	  debris	  in	  the	  lumen	  
of	  organoids,	  making	  background	  subtraction	  to	  gain	  maximum	  contrast	  between	  
the	  two	  difficult.	  	  
	  
Figure	  3.4:	  Immunohistochemistry	  staining	  for	  proliferating	  cells	  with	  Ki67	  
Confocal	  microscope	  images	  of	  proliferating	  cells	  stained	  with	  Ki67	  (green,	  secondary	  raised	  in	  
donkey),	  and	  nuclei	  stained	  with	  Hoechst	  (blue).	  A)	  Represents	  one	  patient	  grown	  under	  control	  
conditions.	  B)	  and	  C)	  are	  from	  the	  same	  patient	  as	  A)	  but	  were	  grown	  in	  the	  presence	  of	  
lipopolysaccharide	  (LPS,	  20	  ng	  ml-­‐1)	  for	  10	  d.	  Red	  arrows	  indicate	  an	  example	  of	  a	  Ki67	  positive	  
proliferating	  cell.	  Yellow	  arrows	  show	  areas	  of	  debris	  in	  the	  cultures,	  which	  the	  antibody	  has	  
bound	  to.	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3.1.2.1 The	  presence	  of	  zones	  of	  proliferation	  in	  enteroids	  
Initial	  measurements	  with	  Ki67	  demonstrated	  that	  the	  distribution	  of	  
proliferating	  nuclei	  was	  not	  uniform	  throughout	  the	  enteroids	  (Fig.	  3.5)	  and	  the	  
proliferating	  cells	  were	  localised	  to	  certain	  areas	  of	  the	  enteroids.	  This	  makes	  
sense	  as	  all	  of	  the	  proliferating	  cells	  arise	  from	  the	  division	  of	  stem	  cells	  
incorporated	  into	  the	  enteroids.	  However,	  this	  meant	  that	  there	  was	  a	  chance	  of	  
sectioning	  an	  enteroid	  in	  either	  a	  region	  of	  high	  or	  low	  density	  of	  proliferating	  
cells,	  potentially	  biasing	  results.	  This	  would	  mean	  serial	  sections	  of	  each	  enteroid	  
would	  be	  required	  to	  ensure	  the	  inclusion	  of	  a	  sufficient	  number	  of	  cells	  so	  results	  
were	  not	  biased.	  To	  avoid	  this,	  whole	  mount	  imaging	  was	  used	  as	  an	  entire	  3-­‐D	  
organoid	  could	  be	  imaged	  and	  quantified.	  These	  results	  will	  be	  presented	  in	  a	  later	  
section.	  	  
	  
Figure	  3.5:	  Example	  of	  non-­‐uniformly	  distributed	  proliferating	  nuclei	  
Representative	  images	  showing	  grouping	  of	  proliferative	  nuclei	  A)	  a	  Ki67	  section,	  with	  a	  single	  
organoid	  highlighted	  by	  the	  yellow	  box	  B)	  schematic	  drawing	  of	  the	  single	  organoid	  and	  the	  
location	  of	  the	  proliferation	  nuclei	  C)	  EdU	  whole	  mount	  image	  of	  an	  organoid	  showing	  grouping	  of	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proliferative	  nuclei	  D)	  representative	  image	  of	  organoid	  from	  yellow	  box	  in	  C),	  showing	  non	  
random	  distribution	  of	  the	  proliferation	  nuclei.	  
3.2 Estimation	  of	  proliferation	  through	  measurement	  
of	  changes	  in	  transcript	  levels	  of	  genes	  associated	  
with	  proliferation	  
In	  these	  experiments	  attempts	  were	  made	  to	  demonstrate	  changes	  in	  
proliferation	  by	  measuring	  changes	  in	  the	  expression	  of	  transcript	  of	  a	  number	  of	  
proliferation-­‐associated	  genes,	  using	  quantitative	  polymerase	  chain	  reaction	  
(qPCR).	  It	  was	  decided	  to	  perform	  qPCR	  analysis	  only	  on	  cDNA	  from	  enteroids	  
because	  they	  most	  closely	  resemble	  the	  in	  vivo	  colonic	  epithelium	  (Gaddeok	  and	  
Butt,	  pers	  comm),	  and	  therefore	  were	  expected	  to	  respond	  to	  changes	  in	  
proliferation	  in	  a	  similar	  manner	  to	  native	  tissues.	  	  
3.2.1 Removal	  of	  growth	  factors	  in	  the	  organoid	  culture	  
media	  
To	  grow	  the	  organoids	  it	  is	  necessary	  to	  include	  a	  number	  of	  growth	  
factors	  in	  the	  media	  to	  maintain	  the	  stem	  cell	  niche	  [75].	  Removing	  the	  factors	  
known	  to	  be	  important	  in	  maintaining	  proliferation	  should	  have	  had	  predictable	  
effects	  on	  proliferation;	  therefore	  they	  would	  act	  as	  a	  good	  control	  to	  show	  that	  
proliferation	  can	  be	  altered	  in	  the	  cultures.	  
qPCR	  experiments	  were	  performed	  on	  enteroids	  that	  were	  grown	  in	  the	  
presence	  of	  normal	  media	  for	  4	  d	  post	  passage,	  followed	  by	  10	  d	  in	  media	  with	  
either	  Wnt3A	  or	  the	  TGF-­‐β	  pathway	  inhibitors	  LY2157299	  and	  SB202190	  
removed.	  The	  mRNA	  transcript	  levels	  were	  then	  measured	  in	  the	  enteroids	  to	  
indicate	  any	  changes	  in	  proliferation	  at	  the	  transcript	  level.	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3.2.1.1 Removal	  of	  Wnt3A	  causes	  a	  small	  change	  in	  some	  
proliferation-­‐associated	  genes	  
As	  Wnt3A	  is	  a	  major	  signalling	  component	  in	  the	  canonical	  Wnt	  signalling	  
pathway,	  it	  was	  expected	  that	  the	  removal	  of	  Wnt3A	  would	  cause	  the	  predicted	  
change	  in	  proliferation-­‐associated	  genes	  as	  a	  result	  of	  decreasing	  proliferation	  
[31].	  Of	  the	  genes	  assessed,	  only	  three	  were	  significantly	  altered	  after	  Wnt3A	  
removal	  (Fig.	  3.6).	  LGR5,	  a	  marker	  of	  colonic	  stem	  cells,	  was	  significantly	  
decreased	  (p<0.001),	  indicating	  that	  Wnt3A	  removal	  causes	  a	  decrease	  in	  the	  stem	  
cell	  population.	  Further	  to	  this,	  a	  significant	  reduction	  in	  FOXM1,	  a	  gene	  associated	  
with	  cyclin	  activation	  and	  subsequent	  cell	  cycle	  progression	  was	  also	  seen	  
(p<0.05),	  indicating	  proliferation	  may	  be	  decreased	  in	  these	  cultures.	  Surprisingly,	  
p15,	  a	  TGF-­‐β	  pathway	  target	  gene	  that	  is	  a	  cyclin	  dependent	  kinase	  inhibitor,	  was	  
decreased	  significantly	  (p<0.05),	  which	  would	  suggest	  a	  decrease	  in	  cell	  cycle	  
inhibition,	  thus	  increased	  proliferation	  [10].	  Unexpectedly,	  the	  proliferation	  
marker	  Ki67	  did	  not	  decrease	  significantly.	  
	  
Figure	  3.6:	  Fold	  change	  in	  mRNA	  expression	  of	  enteroids	  grown	  in	  the	  absence	  of	  Wnt3A	  for	  
10	  d	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All	  changes	  are	  normalised	  to	  the	  geometric	  mean	  of	  the	  housekeeping	  genes	  β-­‐actin,	  RPLPO	  and	  
β2M	  and	  the	  experimental	  values	  expressed	  relative	  to	  the	  controls.	  Statistical	  analysis	  was	  
performed	  using	  an	  unpaired	  Student’s	  t	  test	  comparing	  the	  measured	  values	  to	  the	  control	  value	  
of	  1.	  *	  significantly	  different	  from	  control	  where	  *	  =P<0.05	  and	  ***	  =P<0.001.	  All	  values	  mean	  ±	  
SEM,	  N=5.	  
3.2.1.2 Removal	  of	  the	  TGF-­‐β	  pathway	  inhibitors	  LY2157299	  
and	  SB202190	  has	  no	  effect	  on	  proliferation-­‐associated	  genes	  in	  
enteroids	  
TGF-­‐β	  decreases	  proliferation	  [54;	  10;	  80].	  Under	  normal	  conditions	  it	  is	  
necessary	  to	  include	  inhibitors	  of	  this	  pathway	  in	  the	  growth	  media	  due	  to	  
endogenous	  production	  of	  TGF-­‐β	  by	  the	  epithelial	  cells.	  Therefore,	  removal	  of	  the	  
inhibitors	  should	  have	  a	  predictable	  effect	  on	  the	  proliferation-­‐associated	  genes.	  
This	  acts	  as	  a	  further	  control	  to	  show	  that	  modulating	  the	  organoid	  growth	  
conditions	  can	  affect	  proliferation.	  	  
Surprisingly,	  for	  all	  of	  the	  genes	  that	  were	  assessed	  in	  this	  experiment,	  no	  
significant	  changes	  in	  transcript	  levels	  were	  found	  between	  control	  and	  treated	  
enteroids	  (Fig.	  3.7),	  indicating	  the	  removal	  of	  these	  inhibitors	  has	  no	  significant	  
effect	  on	  enteroid	  proliferation.	  This	  was	  especially	  surprising,	  as	  it	  is	  known	  that	  
p15	  expression	  is	  increased	  with	  TGF-­‐β	  pathway	  activation,	  so	  an	  increase	  in	  this	  
gene	  would	  have	  been	  expected	  [19].	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Figure	  3.7:	  Fold	  change	  in	  mRNA	  expression	  of	  enteroids	  grown	  in	  the	  absence	  of	  TGF-­‐β	  
pathway	  inhibitors	  LY2157299	  and	  SB202190	  for	  10	  d	  	  
All	  changes	  are	  normalised	  to	  the	  geometric	  mean	  of	  the	  housekeeping	  genes	  β-­‐actin,	  RPLPO	  and	  
β2M	  and	  the	  experimental	  values	  expressed	  relative	  to	  the	  controls.	  Statistical	  analysis	  was	  
performed	  using	  an	  unpaired	  Student’s	  t	  test	  comparing	  the	  measured	  values	  to	  the	  control	  value	  
of	  1.	  All	  values	  mean	  ±	  SEM.	  N=5.	  
3.2.2 Addition	  of	  [N-­‐[N-­‐(3,5-­‐difluorophenacetyl)-­‐l-­‐alanyl]-­‐
S-­‐phenylglycinet-­‐butyl	  ester]	  (DAPT)	  to	  organoid	  culture	  media	  	  
The	  γ-­‐secretase	  inhibitor	  DAPT	  affects	  the	  Notch	  signalling	  pathway	  by	  
preventing	  it	  from	  activating	  its	  downstream	  targets	  [24;	  83;	  25].	  This	  results	  in	  a	  
decrease	  in	  proliferation	  and	  an	  increase	  in	  epithelial	  cell	  maturation,	  as	  seen	  by	  a	  
large	  increase	  in	  goblet	  cell	  numbers.	  Due	  to	  this	  known	  function	  it	  should	  cause	  a	  
predictable	  decrease	  in	  proliferation	  in	  enteroids.	  qPCR	  measurements	  were	  
performed	  on	  control	  enteroids	  or	  enteroids	  grown	  in	  normal	  media	  for	  4	  d,	  
followed	  by	  10	  d	  of	  growth	  with	  the	  addition	  of	  DAPT	  (10μM).	  	  
3.2.2.1 Addition	  of	  DAPT	  changes	  the	  proliferation	  marker	  
Ki67	  in	  enteroids	  
The	  Notch	  pathway,	  in	  collaboration	  with	  the	  Wnt	  pathway,	  maintains	  
progenitor	  proliferation,	  and	  its	  inhibition	  would	  favour	  progenitor	  differentiation	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[25].	  Of	  the	  proliferation-­‐associated	  genes	  assessed	  in	  this	  experiment,	  the	  only	  
significant	  change	  was	  a	  decrease	  in	  the	  proliferative	  cell	  marker	  Ki67	  
(p<0.01)(Fig.	  3.8).	  Interestingly,	  variability	  in	  the	  stem	  cell	  marker	  LGR5	  and	  the	  
cell	  cycle	  associated	  gene	  FOXM1	  resulted	  in	  what	  appears	  to	  be	  a	  potential	  
upwards	  trend,	  which	  was	  opposite	  to	  what	  was	  expected.	  The	  significant	  
decrease	  in	  Ki67	  however,	  indicates	  that	  the	  addition	  of	  DAPT	  causes	  a	  decrease	  in	  
the	  number	  of	  proliferative	  cells.	  
	  
Figure	  3.8:	  Fold	  change	  in	  mRNA	  expression	  of	  enteroids	  grown	  in	  the	  presence	  of	  DAPT	  for	  
10	  d	  
All	  changes	  are	  normalised	  to	  the	  geometric	  mean	  of	  the	  housekeeping	  genes	  β-­‐actin,	  RPLPO	  and	  
β2M	  and	  the	  experimental	  values	  expressed	  relative	  to	  the	  controls.	  Statistical	  analysis	  was	  
performed	  using	  an	  unpaired	  Student’s	  t	  test	  comparing	  the	  measured	  values	  to	  the	  control	  value	  
of	  1.	  *	  significantly	  different	  from	  control	  where	  **	  =P<0.01.	  All	  values	  mean	  ±	  SEM.	  N=4.	  
3.2.3 Addition	  of	  bacterial	  components	  to	  organoid	  
culture	  media	  
It	  has	  been	  suggested	  that	  the	  large	  number	  of	  bacteria	  in	  the	  lumen	  may	  
be	  able	  to	  interact	  with	  the	  epithelial	  cells	  to	  alter	  proliferation	  [1].	  A	  mechanism	  
for	  this	  may	  be	  through	  interaction	  with	  the	  PRRs	  found	  on	  the	  surface	  of	  the	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epithelial	  and	  stem	  cells	  (Samuels	  and	  Butt,	  pers	  comm).	  In	  this	  study,	  adding	  
bacterial	  components	  to	  the	  organoid	  cultures	  was	  done	  to	  assess	  their	  effects	  on	  
proliferation.	  After	  4	  d	  of	  growth	  in	  normal	  media,	  enteroids	  were	  exposed	  to	  the	  
common	  bacterial	  component	  lipopolysaccharide	  (LPS)	  across	  a	  range	  of	  
concentrations	  including	  2	  ng	  ml-­‐1,	  20	  ng	  ml-­‐1	  (physiological	  concentration)	  and	  
200	  ng	  ml-­‐1	  (pathological	  concentration)	  for	  10	  d	  as	  well	  as	  200	  ng	  ml-­‐1	  for	  24	  h,	  to	  
assess	  concentration	  and	  time	  dependent	  transcript	  changes.	  They	  were	  also	  
exposed	  to,	  lipoteichoic	  acid	  (LTA,	  20	  ng	  ml-­‐1),	  flagellin	  (20	  ng	  ml-­‐1)	  and	  muramyl	  
dipeptide	  (MDP,	  20	  ng	  ml-­‐1)	  for	  10	  d,	  which	  act	  through	  various	  PRRs	  including	  
TLRs	  and	  NLRs.	  Changes	  in	  the	  transcript	  level	  of	  proliferation-­‐associated	  genes	  
were	  then	  assessed.	  	  
3.2.3.1 Chronic	  LPS	  treatment	  effects	  some	  proliferation	  
associated	  genes	  at	  20	  ng	  ml-­‐1	  but	  not	  at	  2	  ng	  ml-­‐1	  or	  200	  ng	  ml-­‐1	  in	  
enteroids	  
After	  seeing	  that	  proliferation-­‐associated	  genes	  could	  be	  affected	  by	  
altering	  the	  growth	  media,	  the	  effect	  of	  differing	  doses	  of	  LPS,	  a	  component	  of	  
gram-­‐negative	  bacteria,	  on	  proliferation-­‐associated	  genes	  were	  assessed.	  Initially	  
a	  dose	  response,	  spanning	  a	  range	  of	  physiological	  and	  pathological	  
concentrations,	  was	  done	  using	  LPS,	  the	  most	  common	  bacterial	  component	  in	  the	  
lumen,	  to	  assess	  which	  concentration	  of	  bacteria	  would	  generate	  a	  response	  
through	  TLR4	  activation.	  
In	  enteroids	  treated	  with	  either	  2	  ng	  ml-­‐1	  (Fig.	  3.9A)	  or	  200	  ng	  ml-­‐1	  (Fig.	  
3.9C)	  of	  LPS	  for	  10	  d,	  no	  significant	  changes	  in	  the	  genes	  assessed	  were	  seen.	  This	  
indicates	  that	  low	  doses	  of	  LPS,	  along	  with	  exposure	  to	  pathological	  doses	  of	  LPS,	  
has	  no	  effect	  on	  proliferation-­‐associated	  genes.	  In	  the	  presence	  of	  a	  physiological	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dose	  of	  20	  ng	  ml-­‐1	  of	  LPS	  (Fig.	  3.9B),	  only	  one	  significant	  change	  in	  the	  genes	  
assessed	  was	  seen.	  The	  cell	  cycle	  related	  gene	  FOXM1	  increased	  (p<0.05),	  
indicating	  increased	  proliferation	  in	  these	  enteroids	  (Fig.	  3.9B).	  	  
	  
Figure	  3.9:	  Fold	  change	  in	  the	  mRNA	  expression	  of	  enteroids	  grown	  in	  the	  presence	  of	  a	  
range	  of	  concentrations	  for	  LPS	  for	  10	  d	  
Fold	  change	  in	  the	  mRNA	  expression	  for	  proliferation	  associated	  genes	  in	  control	  enteroids	  or	  
enteroids	  grown	  in	  the	  presence	  of	  the	  lipopolysaccharide	  at	  A)	  2	  ng	  ml-­‐1,	  B)	  20	  ng	  ml-­‐1	  and	  C)	  200	  
ng	  ml-­‐1	  for	  10	  d.	  All	  changes	  are	  normalised	  to	  the	  geometric	  mean	  of	  the	  housekeeping	  genes	  β-­‐
actin,	  RPLPO	  and	  β2M	  and	  the	  experimental	  values	  expressed	  relative	  to	  the	  controls.	  Statistical	  
analysis	  was	  performed	  using	  an	  unpaired	  Student’s	  t	  test	  comparing	  the	  measured	  values	  to	  the	  
control	  value	  of	  1.	  *	  significantly	  different	  from	  control	  where	  *	  =P<0.05.	  All	  values	  mean	  ±	  SEM.	  
N=5.	  
3.2.3.2 Short	  term	  treatment	  with	  LPS	  effects	  some	  
proliferation	  associated	  genes	  in	  enteroids	  
To	  assess	  if	  LPS	  caused	  a	  change	  in	  proliferation	  after	  short-­‐term	  
exposure,	  enteroids	  were	  treated	  with	  200	  ng	  ml-­‐1	  LPS	  for	  24	  h	  to	  assess	  any	  rapid	  
changes	  in	  mRNA	  expression	  (Fig.	  3.10).	  A	  significant	  decrease	  in	  the	  TGF-­‐β	  target	  
gene	  p15	  was	  seen	  at	  this	  time	  point	  (p<0.01),	  indicating	  that	  short-­‐term	  exposure	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to	  LPS	  may	  cause	  an	  increase	  in	  proliferation,	  but	  none	  of	  the	  other	  proliferation-­‐
associated	  genes	  changed	  appreciably.	  
	  
Figure	  3.10:	  Fold	  change	  in	  the	  mRNA	  expression	  of	  enteroids	  grown	  in	  the	  presence	  of	  200	  
ng	  ml-­‐1	  LPS	  for	  24	  h	  
All	  changes	  are	  normalised	  to	  the	  geometric	  mean	  of	  the	  housekeeping	  genes	  β-­‐actin,	  RPLPO	  and	  
β2M	  and	  the	  experimental	  values	  expressed	  relative	  to	  the	  controls.	  Statistical	  analysis	  was	  
performed	  using	  an	  unpaired	  Student’s	  t	  test	  comparing	  the	  measured	  values	  to	  the	  control	  value	  
of	  1.	  *	  significantly	  different	  from	  control	  where	  **	  =P<0.01.	  All	  values	  mean	  ±	  SEM.	  N=5.	  	  
3.2.3.3 Lipoteichoic	  acid	  has	  no	  affect	  on	  proliferation	  
associated	  genes	  in	  enteroids	  
Next	  the	  enteroids	  were	  exposed	  to	  lipoteichoic	  acid	  (LTA,	  20	  ng	  ml-­‐1)	  for	  
10	  d.	  This	  was	  done	  to	  see	  what	  effect	  gram-­‐positive	  bacteria,	  and	  activators	  of	  
TLR	  2,	  which	  have	  been	  known	  to	  be	  beneficial	  to	  the	  barrier,	  would	  have	  on	  
proliferation-­‐associated	  genes	  [33].	  From	  this	  experiment,	  no	  significant	  changes	  
in	  any	  proliferation-­‐associated	  genes	  were	  found	  (Fig.	  3.11).	  This	  was	  interesting	  
as	  it	  seems	  LPS	  may	  be	  causing	  a	  change	  in	  proliferation,	  while	  LTA,	  which	  signals	  
via	  a	  different	  TLR	  does	  not	  change	  proliferation.	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Figure	  3.11:	  Fold	  change	  in	  the	  mRNA	  expression	  of	  enteroids	  grown	  in	  the	  presence	  of	  20	  
ng	  ml-­‐1	  LTA	  for	  10	  d	  
All	  changes	  are	  normalised	  to	  the	  geometric	  mean	  of	  the	  housekeeping	  genes	  β-­‐actin,	  RPLPO	  and	  
β2M	  and	  the	  experimental	  values	  expressed	  relative	  to	  the	  controls.	  Statistical	  analysis	  was	  
performed	  using	  an	  unpaired	  Student’s	  t	  test	  comparing	  the	  measured	  values	  to	  the	  control	  value	  
of	  1.	  All	  values	  mean	  ±	  SEM.	  N=5.	  	  
3.2.3.4 Flagellin	  has	  no	  effect	  on	  proliferation	  associated	  
genes	  in	  enteroids	  
The	  effect	  of	  flagellated	  bacteria,	  which	  activate	  TLR5,	  on	  the	  proliferation	  
of	  enteroids,	  was	  assessed	  [45].	  Flagellin	  (20	  ng	  ml-­‐1)	  was	  added	  to	  the	  cultures	  
for	  10	  d,	  after	  being	  grown	  for	  4	  d	  in	  normal	  media.	  There	  was	  no	  statistically	  
significant	  changes	  in	  any	  of	  the	  genes	  investigated	  in	  this	  experiment	  (Fig.	  3.12).	  
This	  was	  surprising	  as	  flagellin	  is	  often	  associated	  with	  pathogenic	  bacteria,	  so	  it	  
would	  be	  expected	  that	  the	  epithelium	  would	  rapidly	  respond	  to	  the	  presence	  of	  
flagellated	  bacteria	  on	  the	  basolateral	  membrane,	  to	  proliferate	  and	  repair	  the	  
barrier.	  However,	  these	  results	  indicate	  that	  flagellated	  bacteria	  do	  not	  effect	  
proliferation	  in	  enteroids.	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Figure	  3.12:	  Fold	  change	  in	  the	  mRNA	  expression	  of	  enteroids	  grown	  in	  the	  presence	  of	  20	  
ng	  ml-­‐1	  flagellin	  for	  10	  d	  	  
All	  changes	  are	  normalised	  to	  the	  geometric	  mean	  of	  the	  housekeeping	  genes	  β-­‐actin,	  RPLPO	  and	  
β2M	  and	  the	  experimental	  values	  expressed	  relative	  to	  the	  controls.	  Statistical	  analysis	  was	  
performed	  using	  an	  unpaired	  Student’s	  t	  test	  comparing	  the	  measured	  values	  to	  the	  control	  value	  
of	  1.	  All	  values	  mean	  ±	  SEM.	  N=3.	  	  
3.2.3.5 Muramyl	  dipeptide	  decreases	  the	  number	  of	  stem	  
cells	  in	  enteroids	  
As	  very	  few	  changes	  were	  seen	  in	  proliferation-­‐associated	  genes	  when	  
various	  TLRs	  were	  stimulated,	  the	  effect	  of	  stimulating	  NLRs	  with	  MDP	  	  on	  
proliferation-­‐associated	  genes	  was	  assessed	  [34;	  61].	  Enteroids	  were	  chronically	  
exposed	  to	  20	  ng	  ml-­‐1	  MDP	  for	  10	  d	  after	  4	  d	  of	  normal	  media	  post	  passage.	  Of	  the	  
genes	  assessed,	  a	  decrease	  in	  the	  stem	  cell	  marker	  LRG5	  was	  the	  only	  significant	  
change	  (p<0.01)	  (Fig.	  3.13).	  This	  indicates	  that	  MDP	  is	  able	  to	  decrease	  the	  
number	  of	  stem	  cells	  in	  the	  enteroid	  cultures.	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Figure	  3.13:	  Fold	  change	  in	  the	  mRNA	  expression	  of	  enteroids	  grown	  in	  the	  presence	  of	  20	  
ng	  ml-­‐1	  MDP	  for	  10	  d	  
All	  changes	  are	  normalised	  to	  the	  geometric	  mean	  of	  the	  housekeeping	  genes	  β-­‐actin,	  RPLPO	  and	  
β2M	  and	  the	  experimental	  values	  expressed	  relative	  to	  the	  controls.	  Statistical	  analysis	  was	  
performed	  using	  an	  unpaired	  Student’s	  t	  test	  comparing	  the	  measured	  values	  to	  the	  control	  value	  
of	  1.	  *	  significantly	  different	  from	  control	  where	  **	  =P<0.01.	  All	  values	  mean	  ±	  SEM.	  N=5.	  	  
3.3 Measuring	  proliferation	  with	  EdU	  staining	  in	  whole	  
mount	  organoids	  
To	  confirm	  the	  changes	  in	  transcript	  level	  were	  being	  translated	  into	  
changes	  in	  proliferation,	  the	  qPCR	  results	  were	  confirmed	  with	  EdU	  whole	  mount	  
imaging.	  This	  method	  allowed	  for	  direct	  measurement	  of	  proliferating	  cells	  in	  
enteroids	  and	  spheroids	  grown	  under	  the	  same	  experimental	  conditions	  as	  the	  
qPCR	  experiments,	  to	  directly	  quantify	  proliferation.	  
3.3.1 Spheroids	  have	  a	  higher	  percentage	  of	  proliferation	  
than	  enteroids	  
There	  was	  a	  marked	  difference	  in	  proliferation	  between	  the	  enteroids	  and	  
spheroids	  grown	  under	  control	  conditions.	  Spheroids	  have	  significantly	  more	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proliferating	  nuclei,	  (P<0.01),	  with	  27	  %±4.6	  of	  cells	  proliferating,	  versus	  5.2	  
%±0.81	  in	  enteroids	  (Fig.	  3.14).	  	  
	  
Figure	  3.14:	  Proportion	  of	  proliferating	  cells	  in	  control	  enteroids	  and	  spheroids	  
Representative	  fluorescent	  microscope	  images	  of	  A)	  a	  spheroid	  and	  B)	  an	  enteroid	  grown	  under	  
control	  conditions.	  Proliferating	  cells	  are	  stained	  with	  EdU	  (green)	  and	  nuclei	  are	  stained	  with	  
Hoechst	  (blue).	  Red	  arrows	  indicate	  EdU	  positive	  proliferative	  nuclei,	  with	  all	  images	  taken	  with	  
20x	  objective.	  C)	  Quantification	  of	  the	  percentage	  of	  proliferating	  cells	  in	  enteroids	  and	  spheroids	  
grown	  under	  control	  conditions.	  Control	  n=6,	  for	  enteroids	  and	  Control	  n=4,	  for	  spheroids,	  where	  
N=2.	  Statistical	  analysis	  was	  performed	  using	  a	  Mann-­‐Whitney	  test,	  *	  significantly	  different	  from	  
control	  where	  **	  =P<0.01.	  All	  values	  mean	  ±	  SEM.	  
3.3.2 Impact	  of	  the	  removal	  of	  Wnt3A	  and	  TGF-­‐β	  pathway	  
inhibitors	  on	  enteroid	  and	  spheroid	  proliferation	  
As	  very	  few	  changes	  in	  gene	  transcripts	  were	  seen,	  and	  the	  spheroids	  and	  
enteroids	  had	  marked	  differences	  in	  proliferation,	  in	  all	  subsequent	  experiments	  
	  60	  
the	  effects	  of	  various	  modifications	  of	  the	  media	  were	  compared	  in	  enteroids	  and	  
spheroids.	  Florescent	  images	  were	  taken	  (Fig.	  3.15A-­‐C)	  and	  proliferation	  was	  
quantified.	  There	  was	  no	  significant	  change	  in	  proliferation	  in	  enteroids	  grown	  in	  
the	  absence	  of	  Wnt3A	  or	  LY2157299	  and	  SB202190	  (Fig.	  3.15D).	  In	  contrast,	  there	  
was	  a	  significant	  decrease	  in	  proliferation	  in	  spheroids	  grown	  in	  the	  absence	  of	  
Wnt3A	  compared	  to	  control	  (P<0.01),	  from	  27	  %±4.6	  to	  5.6	  %±4.3.	  The	  
proliferation	  in	  spheroids	  with	  the	  removal	  of	  LY2157299	  and	  SB202190	  also	  
decreased	  to	  7.6	  %±1.3	  compared	  to	  control,	  however	  this	  was	  not	  significant	  (Fig.	  
3.15E).	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Figure	  3.15:	  Whole	  mount	  EdU	  imaging	  results	  for	  organoids	  grown	  in	  the	  absence	  of	  Wnt3A	  
or	  the	  TGF-­‐β	  pathway	  inhibitors	  LY2157299	  and	  SB202190	  for	  10	  d	  
Representative	  fluorescent	  microscope	  images	  of	  organoids	  that	  were	  grown	  in	  A)	  control	  
conditions	  or	  in	  the	  absence	  of	  B)	  Wnt3A	  or	  C)	  the	  TGF-­‐	  β	  pathway	  inhibitors	  LY2157299	  and	  
SB202190	  for	  10	  d.	  Proliferating	  cells	  are	  stained	  with	  EdU	  (green)	  and	  nuclei	  are	  stained	  with	  
Hoechst	  (blue).	  Red	  arrows	  indicate	  EdU	  positive	  proliferative	  nuclei,	  with	  all	  images	  taken	  with	  
20x	  objective.	  Quantification	  of	  the	  percentage	  of	  proliferation	  for	  D)	  enteroids	  and	  E)	  spheroids	  
grown	  under	  the	  same	  conditions	  are	  shown.	  Control	  n=6,	  minus	  Wnt3A	  n=7	  and	  minus	  LY/SB	  n=8	  
for	  enteroids	  and	  Control	  n=4,	  minus	  Wnt3A	  n=4	  and	  minus	  LY/SB	  n=3	  for	  spheroids,	  where	  N=2.	  
Statistical	  analysis	  was	  performed	  using	  a	  Kruskal	  Wallis	  test,	  using	  a	  Dunns	  post	  test,	  *	  
significantly	  different	  from	  control	  where	  **	  =P<0.01.	  All	  values	  mean	  ±	  SEM.	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3.3.3 Impact	  of	  the	  addition	  of	  DAPT	  on	  enteroid	  and	  
spheroid	  proliferation	  
Images	  of	  enteroids	  and	  spheroids	  were	  taken	  so	  the	  effect	  of	  DAPT	  on	  
proliferation	  could	  be	  quantified	  (Fig.	  3.16A-­‐B).	  Unexpectedly,	  there	  was	  no	  
significant	  change	  in	  enteroids	  grown	  in	  the	  presence	  of	  DAPT	  (Fig.	  3.16C),	  while	  
the	  proliferation	  in	  the	  spheroids	  significantly	  decreased,	  (p<0.05),	  from	  27	  %±4.6	  
to	  3.8	  %±2.6	  (Fig.	  3.16D).	  This	  was	  particularly	  interesting,	  as	  organoids	  grown	  in	  
the	  presence	  of	  DAPT	  looked	  notably	  different	  as	  the	  experiment	  ran,	  with	  both	  a	  
lower	  number	  and	  smaller	  size	  (Fig.	  3.12F)	  compared	  to	  their	  control	  (Fig.	  3.12D).	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Figure	  3.16:	  Whole	  mount	  EdU	  imaging	  results	  for	  organoids	  grown	  in	  the	  presence	  of	  DAPT	  
for	  10	  d	  
Representative	  fluorescent	  microscope	  images	  of	  organoids	  that	  were	  grown	  in	  A)	  control	  
conditions	  or	  the	  absence	  of	  B)	  DAPT	  for	  10	  d.	  Proliferating	  cells	  are	  stained	  with	  EdU	  (green)	  and	  
nuclei	  are	  stained	  with	  Hoechst	  (blue).	  Red	  arrows	  indicate	  EdU	  positive	  proliferative	  nuclei,	  with	  
all	  images	  taken	  with	  20x	  objective.	  Quantification	  of	  the	  percentage	  of	  proliferation	  for	  C)	  
enteroids	  and	  D)	  spheroids	  grown	  under	  the	  same	  conditions	  are	  shown.	  Control	  n=6,	  DAPT	  n=8	  
for	  enteroids	  and	  Control	  n=4,	  DAPT	  n=4	  for	  spheroids,	  where	  N=2.	  Statistical	  analysis	  was	  
performed	  using	  a	  Mann-­‐Whitney	  test,	  ,	  *	  significantly	  different	  from	  control	  where	  *	  =P<0.05.	  All	  
values	  mean	  ±	  SEM.	  Light	  microscope	  images	  of	  cultures	  grown	  under	  E)	  control	  conditions	  or	  F)	  
in	  the	  presence	  of	  DAPT.	  Both	  taken	  at	  4x	  magnification.	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3.3.4 Bacterial	  components	  have	  no	  effect	  on	  enteroid	  
proliferation,	  but	  decrease	  proliferation	  in	  spheroids	  
The	  total	  number	  of	  nuclei	  and	  the	  number	  of	  EdU	  positive	  nuclei	  were	  
counted	  from	  fluorescent	  microscope	  images	  of	  control	  organoids	  or	  organoids	  
grown	  in	  the	  presence	  of	  LPS,	  LTA,	  flagellin	  and	  MDP	  (all	  20	  ng	  ml-­‐1)	  for	  10	  d	  (Fig.	  
3.17A-­‐E).	  Quantification	  of	  these	  results	  showed	  no	  significant	  changes	  in	  the	  
proliferation	  of	  enteroids	  (Fig.	  3.17F),	  which	  agrees	  with	  the	  qPCR	  experiments,	  
where	  very	  few	  changes	  in	  proliferation-­‐associated	  genes,	  or	  in	  some	  cases	  no	  
changes	  in	  proliferation	  associated	  genes	  were	  seen.	  In	  contrast,	  in	  the	  spheroids,	  
a	  significant	  decrease	  in	  proliferation	  was	  seen	  with	  the	  addition	  of	  LPS	  (p<0.05)	  
and	  flagellin	  (p<0.01)	  (Fig.	  3.17G).	  MDP	  and	  LTA	  also	  caused	  a	  decrease	  in	  
proliferation	  in	  spheroids,	  although	  it	  was	  not	  significant.	  Most	  interestingly,	  these	  
results	  suggest	  that	  bacteria	  decrease	  proliferation,	  which	  is	  the	  opposite	  of	  what	  
was	  hypothesised.	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Figure	  3.17:	  Whole	  mount	  EdU	  imaging	  results	  for	  organoids	  grown	  in	  the	  presence	  of	  
bacterial	  components	  for	  10	  days	  	  
Representative	  fluorescent	  microscope	  images	  of	  organoids	  that	  were	  grown	  in	  A)	  control	  
conditions,	  or	  in	  the	  presence	  of	  B)	  LPS	  C)	  LTA	  D)	  flagellin	  and	  E)	  MDP	  (all	  20	  ng	  ml-­‐1)	  for	  10	  d.	  
Proliferating	  cells	  are	  stained	  with	  EdU	  (green)	  and	  nuclei	  are	  stained	  with	  Hoechst	  (blue).	  Red	  
arrows	  indicate	  EdU	  positive	  proliferative	  nuclei,	  with	  all	  images	  taken	  with	  20x	  objective.	  
Quantification	  of	  the	  percentage	  of	  proliferation	  for	  F)	  enteroids	  and	  G)	  spheroids	  grown	  under	  
the	  same	  conditions	  are	  shown.	  Control	  n=6,	  LPS	  n=8	  MDP	  n=9,	  LTA	  n=6	  Flagellin	  n=7	  for	  
enteroids	  and	  Control	  n=4,	  LPS	  n=5	  MDP	  n=3	  LTA	  n=7	  and	  flagellin	  n=4	  for	  spheroids,	  where	  N=2.	  
Statistical	  analysis	  was	  performed	  using	  a	  Kruskal	  Wallis	  test,	  using	  a	  Dunns	  post	  test,	  where	  *	  
significantly	  different	  from	  control	  where	  *	  =P<0.05	  and	  **	  =P<0.01.	  All	  values	  mean	  ±	  SEM.	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4 Discussion	  
The	  intestine	  is	  a	  complex	  system	  made	  up	  of	  a	  number	  of	  aspects,	  which	  
work	  together	  to	  maintain	  homeostasis	  [57].	  Most	  importantly,	  the	  epithelium	  is	  
critical	  in	  creating	  a	  physical	  barrier	  to	  separate	  the	  immune	  cells	  from	  the	  
luminal	  microbes,	  limiting	  microbial	  antigens	  from	  passing	  through	  the	  
epithelium.	  If	  this	  occurs,	  the	  microbial	  antigens	  can	  activate	  immune	  cells,	  
causing	  excessive	  inflammation	  [1;	  74].	  
An	  important	  function	  of	  the	  epithelium	  in	  maintaining	  the	  barrier	  is	  its	  
ability	  to	  be	  rapidly	  renewed,	  resulting	  in	  the	  full	  turnover	  of	  the	  colonic	  
epithelium	  every	  3	  to	  5	  days	  [8].	  This	  mechanism	  is	  driven	  by	  the	  proliferation	  of	  
the	  stem	  cell	  population,	  along	  with	  the	  transit	  amplifying	  (TA)	  cell	  progenitors	  at	  
the	  base	  of	  the	  crypts	  [11;	  52;	  21;	  87].	  These	  stem	  cells,	  along	  with	  their	  
progenitors,	  express	  pattern	  recognition	  receptors	  (PRRs),	  which	  bind	  microbial	  
associated	  molecular	  patterns	  (MAMPs)	  such	  as	  lipopolysaccharide	  	  (LPS)	  and	  
flagellin.	  
The	  epithelial	  cells	  constantly	  interact	  with	  the	  mesenchymal	  and	  immune	  
cells	  along	  with	  the	  microbes	  in	  a	  paracrine	  fashion,	  either	  by	  directly	  binding	  
microbial	  components,	  or	  by	  binding	  cytokines,	  which	  are	  released	  from	  immune	  
and	  mesenchymal	  cells	  in	  response	  to	  bacteria.	  Epithelial	  cells	  also	  act	  in	  an	  
autocrine	  fashion	  and	  secrete	  components	  that	  act	  on	  neighbouring	  epithelial	  cells	  
when	  they	  bind	  bacterial	  components	  [67;	  12;	  4;	  1;	  89].	  The	  lamina	  propria	  is	  
exposed	  to	  low	  concentrations	  of	  microbes	  under	  homeostatic	  conditions	  and	  
alterations	  in	  the	  amount	  of	  microbial	  antigens	  provides	  a	  mechanism	  to	  signal	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barrier	  efficacy,	  which	  can	  be	  recognized	  by	  the	  PRRs	  [86].	  This	  interaction	  may	  
therefore	  help	  to	  regulate	  epithelial	  proliferation.	  
It	  has	  been	  difficult	  to	  study	  the	  epithelium	  alone,	  and	  how	  it	  directly	  
interacts	  with	  its	  surroundings,	  as	  in	  vivo	  models	  include	  the	  epithelium,	  immune	  
and	  mesenchymal	  cells	  [92].	  The	  roles	  of	  immune	  and	  mesenchymal	  cells	  have	  
been	  investigated,	  as	  they	  can	  be	  easily	  isolated	  to	  study,	  something	  that	  has	  
previously	  been	  difficult	  to	  do	  with	  the	  epithelium	  [18;	  79].	  An	  important	  advance	  
was	  the	  development	  of	  organoid	  models,	  3-­‐D	  cultures	  of	  the	  intestinal	  epithelium	  
[75].	  These	  have	  been	  developed	  from	  a	  number	  of	  tissues	  in	  both	  mice	  and	  
humans,	  including	  the	  human	  colonic	  epithelium	  [75].	  In	  culture,	  the	  organoids	  
form	  two	  distinct	  phenotypes.	  Spheroids	  have	  a	  thin,	  immature	  epithelium,	  while	  
enteroids,	  have	  a	  thicker,	  well-­‐defined	  epithelium	  and	  contain	  all	  of	  the	  cell	  types	  
found	  in	  the	  colon	  (Gadeock	  and	  Butt,	  pers	  comm).	  Due	  to	  their	  resemblance	  to	  
the	  in	  vivo	  epithelium,	  the	  enteroids	  are	  commonly	  used	  as	  a	  model	  to	  study	  
intestinal	  epithelial	  aspects.	  Organoids	  provide	  a	  great	  model	  to	  investigate	  how	  
the	  epithelium	  directly	  interacts	  with	  various	  components,	  such	  as	  the	  bacteria,	  
without	  interference	  from	  other	  aspects.	  	  
This	  study	  used	  human	  colonic	  organoids	  to	  investigate	  how	  chronic	  
exposure	  to	  bacterial	  components	  regulated	  proliferation	  of	  the	  colonic	  
epithelium.	  It	  was	  hypothesised	  that	  proliferation	  would	  increase	  in	  the	  mature	  
enteroids,	  as	  bacterial	  stimulation	  of	  the	  basolateral	  PRRs	  would	  indicate	  a	  loss	  of	  
barrier	  integrity.	  Increasing	  proliferation	  to	  regenerate	  the	  epithelium	  and	  limit	  
further	  bacteria	  passing	  into	  the	  lamina	  propria	  in	  response	  to	  this	  would	  seem	  
logical.	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4.1 Proliferation	  in	  enteroids	  and	  spheroids	  	  
Direct	  quantification	  of	  proliferation	  with	  EdU	  revealed	  that	  spheroids	  
were	  proliferating	  significantly	  more	  than	  enteroids,	  with	  27	  %	  ±4.6	  nuclei	  
proliferating	  in	  control	  spheroids,	  versus	  5.2	  %	  ±0.81	  in	  control	  enteroids.	  	  
An	  explanation	  for	  the	  difference	  in	  proliferation	  may	  be	  that	  the	  two	  
morphologies	  are	  derived	  from	  two	  separate	  stem	  cell	  populations.	  These	  include	  
the	  LRG5	  positive	  crypt	  base	  columnar	  cells,	  and	  the	  Bmi1+	  intestinal	  stem	  cells	  
[90].	  LRG5	  positive	  cells	  have	  a	  higher	  proliferative	  rate,	  and	  are	  responsive	  to	  
Wnt,	  as	  its	  activation	  increases	  their	  proliferation,	  and	  Wnt	  inhibition	  with	  DKK-­‐1	  
(Dickkopf	  Homolog	  1)	  decreases	  their	  proliferation.	  Bmi1+	  cells	  on	  the	  other	  hand	  
proliferate	  at	  a	  slower	  rate	  and	  are	  unresponsive	  to	  activation	  or	  inhibition	  of	  the	  
Wnt	  pathway	  [90].	  This	  is	  similar	  to	  what	  is	  seen	  of	  the	  proliferation	  levels	  and	  
Wnt	  responsiveness	  between	  the	  enteroids	  and	  spheroids	  so	  may	  explain	  the	  
differences.	  	  
4.1.1 Effect	  of	  the	  removal	  of	  growth	  factors	  of	  enteroid	  
and	  spheroid	  proliferation	  
Organoid	  cultures	  rely	  on	  a	  number	  of	  growth	  factors	  to	  be	  maintained	  
[75].	  Initial	  investigations	  were	  done	  to	  look	  at	  how	  the	  removal	  of	  these	  
components	  affected	  proliferation.	  The	  removal	  of	  these	  factors	  should	  have	  had	  
predictable	  effects	  on	  proliferation,	  acting	  as	  a	  control	  to	  see	  if	  organoids	  were	  
able	  to	  respond	  to	  environmental	  changes.	  	  
Normal	  proliferation	  within	  the	  crypt	  relies	  on	  activation	  of	  the	  Wnt	  
pathway,	  which	  results	  in	  an	  accumulation	  of	  nuclear	  β-­‐catenin	  and	  subsequent	  
gene	  activation	  [72;	  31;	  70].	  Many	  of	  the	  Wnt	  target	  genes,	  such	  as	  Cyclin	  D1	  and	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MYC	  are	  associated	  with	  the	  cell	  cycle,	  and	  are	  required	  for	  its	  progression	  and	  
thus	  proliferation.	  Therefore,	  removal	  of	  Wnt3A	  from	  the	  culture	  media	  should	  
result	  in	  reduced	  proliferation	  [31].	  The	  removal	  of	  the	  TGF-­‐β	  inhibitors,	  
LY2157299	  and	  SB202190	  should	  also	  cause	  a	  decrease	  in	  proliferation,	  as	  the	  
pathway	  results	  in	  the	  activation	  of	  cell	  cycle	  inhibitors	  such	  as	  p15,	  which	  prevent	  
cell	  cycle	  progression	  [54;	  10;	  80].	  The	  effect	  of	  the	  addition	  of	  DAPT,	  a	  γ-­‐secretase	  
inhibitor	  on	  proliferation	  was	  also	  investigated,	  as	  it	  should	  have	  induced	  a	  
predictable	  decrease	  in	  proliferation.	  DAPT	  inhibits	  the	  Notch	  signalling	  pathway,	  
by	  preventing	  γ-­‐secretase	  from	  cleaving	  the	  intracellular	  domain	  and	  therefore	  
preventing	  downstream	  signalling	  [24;	  83].	  This	  shifts	  the	  balance	  of	  the	  stem	  cell	  
niche,	  and	  results	  in	  a	  large	  increase	  in	  secretory	  cells,	  including	  goblet	  cells	  
(Rodrigues	  and	  Butt,	  pers	  comm),	  which	  should	  be	  associated	  with	  a	  decrease	  in	  
proliferation.	  	  
Alterations	  in	  the	  growth	  environment	  by	  removing	  Wnt3A	  or	  the	  TGF-­‐β	  
pathway	  inhibitors	  LY2157299	  and	  SB202190	  or	  adding	  the	  γ-­‐secretase	  inhibitor	  
DAPT	  unexpectedly	  showed	  no	  significant	  change	  in	  proliferation	  in	  any	  of	  the	  
treated	  enteroids	  compared	  to	  their	  control.	  Instead,	  proliferation	  was	  maintained	  
at	  6.3	  %	  ±0.5	  amongst	  the	  groups.	  Conversely,	  removal	  of	  Wnt3A,	  LY2157299	  and	  
SB202190	  or	  the	  addition	  of	  DAPT	  resulted	  in	  a	  decrease	  in	  proliferation	  in	  the	  
spheroids	  to	  5.6	  %	  ±4.3,	  7.6	  %	  ±1.3	  and	  3.8	  %	  ±2.6	  respectively.	  In	  spheroids	  
grown	  without	  Wnt3A	  or	  in	  the	  presence	  of	  DAPT,	  this	  was	  a	  significant	  decrease.	  
This	  is	  relevant	  as	  it	  shows	  that	  changes	  in	  signalling	  pathways	  that	  are	  known	  to	  
be	  involved	  in	  proliferation	  do	  alter	  proliferation	  in	  the	  spheroids,	  while	  enteroid	  
proliferation	  is	  not	  altered	  in	  response	  to	  environmental	  changes.	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The	  limited	  response	  of	  the	  enteroids	  to	  the	  removal	  of	  growth	  factors	  or	  
the	  addition	  of	  DAPT	  suggests	  they	  be	  a	  model	  to	  study	  the	  mature	  epithelial	  cells,	  
representative	  of	  the	  upper	  portion	  of	  the	  crypts	  in	  vivo	  and	  how	  they	  respond	  to	  
different	  conditions.	  In	  vivo	  Wnt	  activation,	  via	  R-­‐spondin	  causes	  an	  increase	  in	  
proliferation	  of	  the	  stem	  cells,	  while	  having	  no	  effect	  on	  differentiation	  or	  the	  
mature	  cell	  types,	  which	  would	  make	  up	  the	  enteroids	  in	  this	  model	  [43].	  It	  
follows	  then,	  that	  spheroids	  may	  represent	  the	  crypt	  base	  in	  vivo,	  and	  provide	  a	  
better	  model	  to	  study	  proliferation,	  and	  how	  the	  stem	  and	  progenitor	  cells	  react	  to	  
environmental	  changes,	  especially	  as	  they	  are	  responsive	  to	  external	  stimuli	  such	  
as	  Wnt.	  
Although	  a	  decrease	  in	  proliferation	  was	  the	  expected	  result	  from	  all	  of	  
these	  experiments,	  seeing	  a	  significant	  decrease	  occur	  in	  the	  spheroids,	  rather	  
than	  the	  enteroids	  was	  intriguing.	  Previous	  experimental	  work	  using	  organoids	  
for	  the	  most	  part,	  fail	  to	  mention	  the	  fact	  that	  two	  different	  morphologies	  develop	  
in	  these	  cultures;	  instead	  focusing	  on	  the	  mature	  enteroids,	  with	  little	  to	  no	  
mention	  of	  spheroids	  [60;	  47;	  61].	  
This	  study’s	  findings	  indicate	  that	  in	  these	  cultures,	  and	  potentially	  within	  
the	  crypt,	  there	  is	  a	  basal	  level	  of	  proliferation.	  Spheroids	  have	  a	  comparatively	  
high	  level	  of	  proliferation	  (27	  %	  ±4.6	  versus	  5.2	  %	  ±0.81	  in	  control	  enteroids),	  
which	  can	  be	  altered	  by	  their	  environment.	  In	  response	  to	  the	  removal	  of	  growth	  
factors,	  spheroid	  proliferation	  was	  decreased	  to	  a	  similar	  basal	  level	  of	  
proliferation	  as	  enteroids	  from	  27	  %	  ±4.6	  to	  9.6	  %	  ±1.4.	  In	  contrast,	  enteroids	  
maintained	  a	  stable,	  low	  level	  of	  proliferation	  (average	  of	  6.3	  %	  ±0.5	  across	  all	  
experiments),	  despite	  environmental	  alterations.	  Proliferation	  was	  always	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maintained	  at	  around	  6	  %	  in	  these	  cultures,	  and	  never	  fully	  lost.	  It	  is	  logical	  that	  
proliferation	  would	  be	  maintained	  in	  vivo,	  as	  complete	  loss	  of	  proliferation	  would	  
have	  a	  negative	  effect	  on	  the	  barrier.	  It	  would	  prevent	  regeneration	  of	  the	  barrier,	  
and	  the	  ability	  to	  repair	  damage,	  allowing	  bacteria	  to	  pass	  through	  the	  epithelium.	  
If	  the	  balance	  between	  proliferation	  and	  differentiation	  is	  disrupted,	  other	  
signalling	  pathways	  may	  also	  be	  able	  to	  take	  over	  to	  stimulate	  proliferation	  to	  
maintain	  the	  barrier.	  For	  example,	  when	  Wnt3A	  was	  removed,	  the	  Wnt	  pathway	  
agonist	  R-­‐spondin	  was	  still	  in	  the	  culture	  media.	  Various	  models	  have	  linked	  R-­‐
spondin	  to	  inducing	  β-­‐catenin	  stabilisation	  and	  a	  subsequent	  increase	  in	  
proliferation	  [42;	  43].	  Functional	  analysis,	  using	  reporter	  assays,	  have	  shown	  R-­‐
spondin	  enhances	  Wnt3A	  signalling,	  thus	  it	  acts	  at	  the	  receptor	  level,	  to	  stimulate	  
this	  pathway	  [42].	  Although	  some	  literature	  suggests	  loss	  of	  Wnt	  signalling	  
completely	  ablates	  proliferation,	  often	  Wnt	  pathway	  inhibitors	  such	  as	  DKK-­‐1	  are	  
used	  to	  completely	  block	  the	  pathway.	  The	  inhibitors	  also	  affect	  the	  ability	  of	  R-­‐
spondin	  to	  agonise	  the	  pathway	  to	  activate	  it	  [42;	  43].	  Here,	  the	  pathway	  is	  not	  
inhibited,	  so	  retaining	  R-­‐spondin	  in	  the	  culture	  media	  may	  provide	  enough	  of	  a	  
signal	  to	  maintain	  the	  low	  levels	  of	  proliferation	  seen	  in	  the	  experiment	  when	  
Wnt3A	  was	  removed.	  	  
Along	  the	  same	  lines,	  a	  complete	  loss	  of	  proliferation	  was	  not	  seen	  with	  
the	  removal	  of	  the	  TGF-­‐β	  pathway	  inhibitors.	  These	  cultures	  still	  had	  Wnt3A	  
present,	  which	  could	  provide	  a	  proliferative	  signal.	  In	  addition,	  R-­‐spondin	  can	  also	  
inhibit	  TGF-­‐β	  signalling	  and	  adding	  to	  this,	  the	  TGF-­‐β	  pathway	  was	  only	  
uninhibited,	  not	  stimulated,	  explaining	  why	  a	  basal	  level	  of	  proliferation	  was	  
maintained	  [42].	  Finally,	  despite	  the	  Notch	  pathway	  being	  inhibited	  by	  DAPT,	  the	  
	  73	  
presence	  of	  Wnt3A	  in	  the	  media	  could	  be	  sufficient	  to	  stimulate	  stem	  cell	  division,	  
so	  a	  complete	  loss	  of	  proliferation	  was	  not	  seen.	  
4.1.2 Effect	  of	  bacterial	  components	  on	  enteroid	  and	  
spheroid	  proliferation	  	  	  	  
The	  lumen	  of	  the	  colon	  contains	  the	  largest	  number	  of	  microbes	  in	  the	  
body.	  A	  number	  of	  mechanisms	  are	  in	  place	  to	  limit	  them	  passing	  across	  the	  
epithelium	  and	  coming	  into	  contact	  with	  immune	  cells.	  The	  epithelial	  and	  stem	  
cells,	  including	  those	  in	  the	  organoid	  cultures,	  have	  PRRs	  on	  their	  surface	  
(Samuels	  and	  Butt,	  pers	  comm),	  allowing	  them	  to	  recognise	  and	  respond	  to	  
microbial	  associated	  molecular	  patterns	  (MAMPs).	  Bacterial	  components	  on	  the	  
basolateral	  membrane	  would	  act	  as	  a	  danger	  signal,	  leading	  to	  the	  hypothesis	  that	  
stimulating	  them	  would	  signal	  a	  loss	  of	  the	  efficacy	  of	  the	  barrier	  and	  thus	  result	  
in	  an	  increase	  in	  proliferation	  to	  aid	  in	  repair	  of	  the	  barrier.	  
There	  are	  a	  number	  of	  different	  microbes	  in	  the	  body,	  which	  all	  contain	  
different	  MAMPs,	  and	  therefore	  activate	  different	  PRRs	  [16;	  21;	  51].	  These	  include	  
lipopolysaccharide	  (LPS),	  which	  stimulates	  TLR4,	  lipoteichoic	  acid	  (LTA)	  which	  
stimulates	  TLR2,	  flagellin,	  which	  stimulates	  TLR5	  and	  muramyl	  dipeptide	  (MDP),	  
which	  stimulates	  nod-­‐like	  receptors	  (NLRs)[30;	  34;	  13;	  60;	  74;	  33].	  In	  this	  study,	  a	  
wide	  array	  of	  MAMPs	  and	  their	  effects	  on	  proliferation	  were	  tested,	  not	  only	  to	  see	  
if	  bacterial	  components	  regulate	  epithelial	  proliferation	  through	  basolateral	  PRR	  
signalling,	  but	  because	  it	  would	  help	  to	  identify	  any	  differential	  effects	  on	  
proliferation,	  based	  on	  bacteria	  type	  or	  the	  subsequent	  PRR	  that	  is	  activated.	  	  
Direct	  quantification	  of	  proliferation	  with	  EdU	  showed	  no	  significant	  
changes	  in	  enteroid	  proliferation	  when	  exposed	  to	  bacterial	  components.	  Instead	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they	  maintained	  a	  low	  level	  of	  basal	  proliferation.	  Similar	  to	  what	  was	  seen	  with	  
the	  removal	  of	  growth	  factors,	  the	  proliferation	  in	  spheroids	  exposed	  to	  bacterial	  
components	  decreased	  from	  27	  %	  ±4.6	  to	  9.6	  %	  ±1.4.	  Proliferation	  decreased	  to	  a	  
similar	  level	  to	  control	  enteroids,	  strengthening	  the	  argument	  that	  there	  is	  a	  basal	  
level	  of	  proliferation	  and	  that	  the	  spheroids,	  in	  this	  culture	  system	  provide	  a	  
better	  model	  for	  studying	  proliferation.	  	  
4.1.2.1 Effects	  of	  LPS	  stimulation	  of	  TLR4	  on	  proliferation	  
Spheroids	  treated	  with	  LPS,	  which	  acts	  via	  TLR4,	  had	  a	  significant	  
decrease	  in	  proliferation	  from	  27	  %	  ±4.6	  to	  6.2	  %	  ±1.5.	  Injecting	  mice,	  bred	  in	  
germ	  free	  conditions,	  with	  LPS	  and	  subsequently	  studying	  their	  intestine,	  has	  
revealed	  that	  LPS	  stimulates	  a	  decrease	  in	  intestinal	  stem	  cell	  proliferation	  in	  a	  
TLR4	  dependent	  manner	  [60].	  In	  contrast	  to	  this,	  constitutive	  activation	  of	  TLR4	  
in	  transgenic	  mice	  resulted	  in	  an	  increase	  in	  the	  number	  of	  proliferative	  cells,	  
accompanied	  by	  increased	  crypt	  length	  [74].	  As	  activating	  the	  pathway	  with	  an	  
agonist,	  rather	  than	  continually	  activating	  it	  via	  a	  transgene,	  is	  more	  
representative	  of	  the	  model	  used	  in	  this	  study,	  the	  results	  from	  Neal	  et	  al.,	  (2012,	  )	  
are	  more	  relevant	  to	  the	  findings	  here,	  and	  they	  show	  a	  similar	  result.	  
4.1.2.2 Effects	  of	  LTA	  stimulation	  of	  TLR2	  on	  proliferation	  
There	  was	  an	  indication	  of	  a	  decrease	  in	  the	  proliferation	  of	  spheroids	  
treated	  with	  LTA,	  a	  TLR2	  agonist,	  although	  this	  decrease	  did	  not	  reach	  
significance.	  In	  cell	  lines,	  LTA	  has	  been	  shown	  to	  increase	  proliferation.	  This	  may	  
be	  explained	  by	  the	  fact	  that	  often	  cell	  lines	  fail	  to	  replicate	  many	  of	  the	  colonic	  
characteristics	  seen	  in	  vivo	  due	  to	  being	  clonal	  in	  nature	  [33;	  50]	  In	  mice	  models,	  
LTA	  from	  bacteria	  which	  have	  been	  allowed	  to	  colonise	  the	  mouse	  small	  intestine,	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can	  stimulate	  an	  increase	  in	  proliferation	  [33].	  However,	  in	  in	  vivo	  models	  the	  
response	  will	  involve	  the	  immune	  and	  mesenchymal	  cells,	  which	  may	  explain	  why	  
an	  increase	  in	  proliferation	  was	  seen.	  The	  link	  between	  LTA	  stimulation	  and	  
proliferation	  is	  however,	  an	  area	  that	  is	  understudied.	  
4.1.2.3 Effects	  of	  flagellin	  stimulation	  of	  TLR5	  on	  proliferation	  
A	  significant	  decrease	  in	  proliferation	  from	  27	  %	  ±4.6	  to	  4.8	  %	  ±1.7	  was	  
seen	  in	  flagellin	  treated	  spheroids.	  Flagellin	  is	  another	  MAMP,	  which	  activates	  
TLR5	  and	  has	  only	  just	  begun	  to	  be	  investigated	  in	  the	  context	  of	  epithelial	  
proliferation.	  So	  far,	  mouse	  models	  have	  been	  used	  to	  examine	  its	  effects.	  
Irradiation	  damage	  to	  cause	  intestinal	  damage	  in	  mice	  was	  followed	  by	  the	  
administration	  of	  flagellin	  to	  the	  intestine.	  This	  resulted	  in	  an	  increase	  in	  intestinal	  
regeneration	  and	  proliferation	  [45].	  This	  was	  the	  opposite	  effect	  to	  what	  has	  been	  
seen	  in	  this	  current	  study.	  The	  increase	  in	  proliferation	  in	  the	  mouse	  was	  however	  
linked	  to	  an	  increase	  in	  macrophage	  infiltration	  to	  the	  site	  of	  damage,	  as	  well	  as	  an	  
increase	  in	  macrophage	  activation,	  which	  may	  explain	  the	  differences	  [45].	  
4.1.2.4 Effects	  of	  MDP	  stimulation	  of	  NLRs	  on	  proliferation	  
Although	  a	  decrease	  in	  proliferation	  in	  the	  spheroids	  treated	  with	  MDP	  
was	  seen,	  this	  was	  not	  a	  significant.	  Until	  recently,	  there	  has	  been	  little	  research	  on	  
the	  link	  between	  MDP	  and	  proliferation	  in	  the	  intestine.	  In	  organoids	  grown	  from	  
mouse	  small	  intestine,	  stimulation	  with	  MDP,	  in	  a	  similar	  way	  to	  that	  performed	  
here,	  caused	  no	  change	  in	  proliferation,	  despite	  a	  much	  higher	  dose	  of	  MDP	  being	  
used	  (10	  μg/mL)	  [61].	  Interestingly,	  the	  authors	  noted	  that	  although	  MDP	  caused	  
no	  changes	  in	  growth,	  it	  helped	  with	  stem	  cell	  survival	  [61].	  Initially,	  it	  seems	  this	  
result	  is	  the	  opposite	  to	  what	  was	  seen	  in	  the	  current	  study,	  however	  after	  careful	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scrutiny	  of	  the	  paper,	  all	  of	  the	  images	  of	  the	  organoids	  that	  are	  shown	  are	  of	  
mature	  enteroids.	  This	  then	  agrees	  with	  the	  results	  found	  in	  this	  current	  study,	  
that	  enteroid	  proliferation	  does	  not	  change	  when	  stimulated	  with	  MDP.	  However	  
the	  effects	  on	  the	  spheroids	  cannot	  be	  confirmed,	  as	  this	  paper	  makes	  no	  mention	  
of	  the	  spheroid	  population.	  
4.2 Changes	  in	  mRNA	  transcript	  levels	  of	  proliferation-­‐
associated	  genes	  in	  response	  to	  environmental	  
modifications	  in	  enteroids	  
qPCR	  was	  performed	  on	  enteroid	  cDNA,	  as	  enteroids	  are	  considered	  to	  be	  
the	  structure	  that	  most	  closely	  resembles	  the	  in	  vivo	  colonic	  epithelium,	  as	  it	  was	  
anticipated	  that	  they	  would	  respond	  as	  predicted.	  Directly	  quantifying	  
proliferation	  with	  EdU	  in	  enteroids	  grown	  under	  control	  and	  experimental	  
conditions	  resulted	  in	  no	  significant	  changes	  in	  proliferation.	  For	  the	  most	  part,	  
the	  same	  results	  were	  seen	  in	  the	  proliferation-­‐associated	  genes	  that	  were	  
assessed	  at	  the	  transcript	  level.	  	  
There	  were	  some	  exceptions	  as	  a	  few	  proliferation-­‐associated	  genes	  did	  
significantly	  change	  in	  some	  of	  the	  experimental	  conditions.	  There	  were	  
significant	  changes	  in	  proliferation-­‐associated	  genes	  when	  Wnt3A	  was	  removed,	  
although	  they	  were	  contradictory.	  The	  stem	  cell	  marker	  LGR5	  significantly	  
decreased,	  which	  indicates	  a	  number	  of	  things.	  Firstly,	  LGR5	  is	  a	  target	  gene	  of	  the	  
Wnt	  pathway,	  hence	  its	  decrease	  was	  expected,	  and	  indicates	  that	  removing	  
Wnt3A	  has	  decreased	  the	  number	  of	  slow	  cycling	  stem	  cells	  [8].	  Wnt	  also	  controls	  
the	  division	  of	  rapidly	  amplifying	  TA	  cells,	  so	  it	  can	  effect	  proliferation	  in	  this	  way,	  
although	  it	  would	  have	  been	  anticipated	  a	  decrease	  in	  proliferation	  would	  be	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evident	  as	  a	  decrease	  in	  Ki67	  transcript	  levels.	  FOXM1	  is	  associated	  with	  cell	  cycle	  
progression	  [91].	  Overexpression	  of	  FOXM1	  is	  associated	  with	  metastasis	  and	  
tumour	  progression,	  while	  knocking	  down	  the	  gene	  using	  shRNA	  results	  in	  a	  
decrease	  in	  proliferation	  of	  colon	  cancers	  [91].	  A	  significant	  decrease	  in	  FOXM1,	  
therefore	  indicated	  a	  decrease	  in	  proliferation	  in	  the	  enteroids.	  FOXM1	  can	  affect	  
both	  the	  stem	  and	  TA	  cell	  population,	  further	  enforcing	  the	  decrease	  seen	  in	  LRG5,	  
while	  surprisingly	  here,	  having	  no	  effect	  on	  Ki67	  [29].	  Unexpectedly,	  the	  cell	  cycle	  
inhibitor	  p15	  also	  significantly	  decreased,	  indicating	  increased	  proliferation.	  This	  
change	  may	  be	  due	  to	  a	  small,	  transient	  change	  in	  the	  gene’s	  activation,	  or	  the	  
results	  of	  some	  rapidly	  induced	  change	  that	  was	  not	  seen	  due	  to	  the	  long	  time	  
course	  of	  these	  experiments.	  
The	  addition	  of	  DAPT	  resulted	  in	  a	  decrease	  in	  the	  proliferation	  marker	  
Ki67.	  This	  was	  predicted	  as	  Notch	  pathway	  inactivation	  via	  DAPT	  results	  in	  
terminal	  differentiation	  and	  is	  associated	  with	  reduced	  proliferation	  [47].	  
Interestingly,	  no	  change	  in	  the	  stem	  cell	  marker	  LGR5	  was	  seen.	  This	  may	  be	  due	  
to	  Wnt3A	  being	  maintained	  in	  the	  media	  and	  continuing	  to	  activate	  the	  Wnt	  
pathway.	  This	  would	  signal	  to	  maintain	  the	  slow	  proliferating	  LGR5	  stem	  cells,	  
while	  DAPT	  pushed	  the	  rapidly	  proliferating	  TA	  cells	  to	  terminally	  differentiate,	  
decreasing	  overall	  proliferation.	  
Despite	  a	  range	  of	  concentrations	  and	  time	  points	  for	  LPS	  stimulation	  
being	  tested,	  only	  two	  significant	  changes	  in	  genes	  were	  seen.	  A	  decrease	  in	  the	  
cell	  cycle	  associated	  gene	  FOXM1	  with	  20ng	  ml-­‐1	  LPS	  for	  10	  d	  suggested	  an	  
increase	  in	  the	  proliferation.	  However,	  FOXM1	  is	  able	  to	  act	  on	  both	  the	  LGR5	  
positive	  stem	  cells	  and	  the	  TA	  cells,	  so	  no	  changes	  in	  the	  LGR5	  gene,	  or	  the	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proliferative	  marker	  Ki67,	  make	  it	  difficult	  to	  interpret	  how	  this	  increase	  in	  FOXM1	  
may	  be	  causing	  an	  increase	  in	  proliferation.	  A	  significant	  decrease	  in	  the	  cell	  cycle	  
inhibitor	  p15	  in	  enteroids	  treated	  with	  200ng	  ml-­‐1	  LPS	  for	  24	  h,	  was	  also	  seen,	  
suggesting	  an	  increase	  in	  proliferation	  through	  decreased	  cell	  cycle	  inhibition,	  but	  
again,	  it	  is	  difficult	  to	  interpret	  how	  this	  change	  in	  proliferation	  is	  occurring,	  if	  at	  
all,	  when	  LGR5	  and	  Ki67	  did	  not	  significantly	  change.	  Maybe	  these	  changes	  were	  
small	  transient	  changes,	  with	  no	  overall	  impact	  on	  proliferation.	  
With	  MDP	  treatment,	  the	  only	  significant	  change	  was	  a	  decrease	  in	  LGR5.	  
This	  suggests	  that	  MDP,	  and	  subsequent	  activation	  of	  NLRs	  causes	  a	  decrease	  in	  
the	  number	  of	  slow	  cycling	  stem	  cells	  found	  at	  the	  base	  of	  the	  crypts,	  while	  having	  
no	  effect	  on	  the	  rapidly	  proliferating	  TA	  cell	  population	  and	  therefore	  overall	  
proliferation.	  	  
Unexpectedly,	  the	  removal	  of	  LY2157299	  and	  SB202190	  resulted	  in	  no	  
significant	  changes	  in	  any	  of	  the	  genes	  assessed.	  This	  was	  unpredicted,	  as	  p15	  is	  
produced	  as	  a	  result	  of	  TGF-­‐β	  activation,	  so	  in	  these	  experiments	  it	  was	  expected	  
to	  increase	  [10].	  An	  explanation	  may	  be	  that	  the	  change	  in	  TGF-­‐β	  pathway	  activity	  
was	  small,	  as	  the	  TGF-­‐β	  pathway	  was	  not	  activated	  by	  the	  addition	  of	  its	  agonists,	  
instead	  only	  the	  inhibitors	  of	  the	  pathway	  were	  removed,	  therefore	  no	  significant	  
changes	  were	  seen.	  	  
4.3 Conclusions	  
Overall,	  although	  these	  results	  were	  exciting,	  they	  were	  unexpected.	  Not	  
only	  were	  changes	  in	  proliferation	  expected	  to	  be	  seen	  in	  the	  enteroids	  and	  not	  
spheroids,	  but	  it	  was	  also	  hypothesised	  that	  bacterial	  components	  would	  cause	  an	  
increase,	  not	  a	  decrease	  in	  proliferation.	  Decreasing	  proliferation	  in	  response	  to	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bacterial	  recognition,	  which	  should	  be	  a	  danger	  signal	  when	  at	  the	  basolateral	  
membrane,	  seems	  counterintuitive,	  as	  it	  would	  limit	  the	  ability	  to	  repair	  the	  
damaged	  barrier.	  Potentially	  one	  explanation	  for	  this	  is	  the	  dose	  of	  LPS	  used	  in	  the	  
whole	  mount	  experiments.	  Evidence	  of	  changed	  proliferation	  in	  germ	  free	  mice	  
compared	  to	  those	  that	  have	  a	  normal	  flora	  suggest	  a	  role	  for	  the	  microbes	  in	  
maintaining	  homeostatic	  conditions,	  including	  proliferation	  and	  repair	  [93].	  Since	  
low	  doses	  of	  LPS	  (20	  ng	  ml-­‐1)	  were	  used	  here,	  they	  may	  have	  been	  similar	  to	  
physiological	  conditions.	  Potentially,	  if	  a	  pathological	  dose	  of	  LPS	  were	  used	  (200	  
ng	  ml-­‐1),	  this	  would	  cause	  a	  different	  response	  and	  potentially	  result	  in	  an	  increase	  
in	  proliferation	  in	  spheroids,	  although	  high	  doses	  of	  LPS	  had	  no	  effect	  on	  
proliferation-­‐associated	  genes	  in	  enteroids.	  
Another	  explanation	  may	  be	  that	  regulation	  of	  epithelial	  proliferation	  
requires	  input	  from	  other	  external	  factors,	  rather	  than	  a	  direct	  interaction	  with	  
the	  bacteria.	  In	  vivo	  along	  with	  the	  epithelium,	  there	  are	  also	  immune	  cells	  and	  
underlying	  mesenchymal	  cells	  present,	  both	  of	  which	  can	  interact	  with	  the	  
microbes	  and	  the	  epithelium	  [7].	  The	  epithelium	  may	  also	  rely	  on	  substances	  such	  
as	  cytokines	  being	  released	  from	  the	  mesenchyme	  and	  immune	  cells	  to	  initiate	  an	  
increase	  in	  proliferation	  and	  subsequent	  barrier	  regeneration.	  This	  would	  explain	  
why	  some	  whole	  mouse	  models,	  such	  as	  that	  used	  by	  Santaolalla	  et	  al.,	  (2013,	  )	  
saw	  an	  increase	  in	  proliferation,	  as	  all	  of	  these	  intestinal	  components	  were	  
present.	  Along	  with	  this,	  a	  study	  in	  mice	  showed	  that	  germ	  free,	  or	  MyD88-­‐/-­‐	  (an	  
important	  protein	  in	  TLR	  signalling)	  mice	  had	  shortened	  crypts	  and	  decreased	  
proliferation	  following	  dextran	  sulfate	  sodium	  (DSS)	  treatment.	  In	  contrast,	  wild	  
type	  mice	  had	  increased	  colonic	  progenitor	  proliferation,	  accompanied	  by	  an	  
increase	  in	  immune	  cell	  infiltrate,	  suggesting	  the	  recruitment	  of	  immune	  cells,	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stimulated	  by	  bacterial	  presence,	  is	  required	  for	  barrier	  regeneration	  [68].	  
Similarly,	  epithelial	  damage	  via	  irradiation,	  followed	  by	  subsequent	  addition	  of	  
flagellin	  in	  mice,	  caused	  epithelial	  regeneration	  in	  a	  macrophage	  dependent	  
manner	  [45].	  Further	  supporting	  the	  need	  for	  other	  intestinal	  elements	  to	  induce	  
an	  increase	  in	  proliferation,	  is	  the	  effect	  of	  cytokines	  such	  as	  TNFα	  and	  IFNγ,	  
which	  are	  produced	  by	  immune	  cells	  in	  response	  to	  microbes	  [40].	  This	  has	  been	  
seen	  in	  cell	  lines,	  where	  CCD-­‐18Co	  normal	  colon	  cells	  were	  stimulated	  with	  a	  
range	  of	  TNFα	  concentrations	  and	  an	  increase	  in	  the	  cell	  growth	  was	  seen	  [81].	  
This	  indicates	  that	  other	  components,	  aside	  from	  bacteria	  and	  the	  epithelium	  
alone,	  are	  required	  to	  cause	  an	  increase	  in	  proliferation.	  
These	  results	  firstly	  show	  that	  the	  spheroids	  in	  this	  culture	  system,	  
despite	  often	  being	  ignored,	  may	  provide	  a	  model	  of	  the	  proliferative	  zone	  of	  the	  
colon,	  compared	  with	  the	  mature	  enteroids.	  It	  was	  also	  found	  that	  a	  basal	  level	  of	  
proliferation	  in	  these	  cultures	  is	  maintained	  despite	  environmental	  changes,	  to	  
allow	  the	  continual	  maintenance	  of	  the	  organoids.	  Interestingly,	  this	  study	  
demonstrated	  that	  bacterial	  components	  decreased	  proliferation	  in	  the	  spheroids	  
by	  directly	  interacting	  with	  the	  epithelial	  cells,	  in	  the	  absence	  of	  immune	  or	  
mesenchymal	  mediators.	  	  
Importantly,	  these	  results	  have	  been	  obtained	  by	  using	  a	  new	  and	  novel	  
culture	  system,	  where	  3-­‐D	  structures	  derived	  from	  human	  colonic	  stem	  cells	  are	  
formed.	  This	  means	  they	  provide	  an	  unparalleled	  model	  to	  study	  the	  direct	  effects	  
of	  environmental	  changes	  or	  bacterial	  components,	  as	  well	  as	  many	  other	  things,	  
on	  the	  epithelium	  alone,	  without	  the	  interference	  of	  other	  cell	  types.	  Also,	  as	  it	  is	  a	  
model	  derived	  from	  human	  tissue,	  the	  relevance	  of	  the	  findings	  to	  the	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physiological	  context	  of	  the	  human	  colon	  is	  much	  greater	  than	  those	  obtained	  
from	  animal	  models.	  
4.4 Limitations	  
Despite	  gaining	  some	  interesting	  results	  from	  this	  study,	  there	  were	  
limitations.	  Organoids	  are	  a	  relatively	  new	  culture	  system,	  allowing	  the	  long-­‐term	  
expansion	  of	  human	  colonic	  stem	  cells	  in	  a	  way	  that	  replicates	  the	  in	  vivo	  
epithelium.	  Although	  this	  provides	  a	  large	  number	  of	  benefits,	  such	  as	  being	  one	  of	  
the	  few	  models	  that	  uses	  human	  cells,	  and	  allows	  for	  the	  study	  of	  the	  pure	  
epithelium	  alone,	  and	  its	  response	  to	  various	  factors,	  there	  are	  also	  drawbacks.	  	  
Compared	  to	  other	  culture	  systems,	  organoids	  are	  relatively	  slow	  
growing,	  only	  being	  able	  to	  be	  passaged	  once	  every	  5-­‐7	  days.	  Amplification	  also	  
takes	  some	  time,	  as	  the	  organoids	  can’t	  be	  split	  too	  hard,	  or	  the	  culture	  will	  
struggle	  to	  recover.	  Usually	  the	  number	  of	  wells	  can	  be	  doubled	  on	  a	  passage,	  or	  
sometimes,	  if	  they	  are	  growing	  well,	  be	  amplified	  from	  one	  well	  into	  three	  wells.	  
For	  the	  use	  of	  high-­‐powered	  techniques	  such	  as	  flow	  cytometry,	  a	  balance	  
between	  amplification,	  and	  maintaining	  organoid	  numbers	  in	  each	  well	  is	  
required,	  as	  techniques	  such	  as	  this	  require	  a	  large	  number	  of	  cells.	  	  
This	  was	  one	  of	  the	  reasons	  why	  it	  was	  not	  possible	  to	  use	  flow	  cytometry	  
in	  this	  study.	  For	  all	  of	  the	  controls	  and	  a	  single	  treatment,	  8	  wells	  minimum	  were	  
required,	  and	  due	  to	  the	  slow	  growth,	  it	  would	  take	  time	  to	  amplify	  to	  this	  number	  
of	  wells.	  Also,	  due	  to	  the	  slow	  growth,	  even	  if	  8	  wells	  could	  be	  grown	  there	  was	  a	  
low	  number	  of	  cells	  compared	  to	  a	  confluent	  monolayer	  of	  cells	  from	  a	  cell	  line	  
with	  anywhere	  between	  3,000-­‐7,000	  compared	  to	  100,000,	  making	  it	  difficult	  to	  
get	  precise	  results	  with	  this	  technique.	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4.5 Further	  Research	  
This	  research	  raises	  a	  number	  of	  new	  questions	  which	  need	  to	  be	  
answered	  to	  better	  understand	  colonic	  epithelial	  proliferation.	  As	  the	  spheroids	  
are	  a	  better	  model	  of	  colonic	  proliferation,	  more	  investigation	  into	  understanding	  
them	  is	  needed.	  To	  begin	  with,	  looking	  at	  the	  same	  group	  of	  proliferation-­‐
associated	  genes	  investigated	  in	  this	  study,	  using	  cDNA	  from	  spheroids,	  to	  see	  if	  
the	  expected	  changes	  occur	  in	  them,	  as	  no	  changes	  were	  seen	  in	  the	  enteroids.	  
Doing	  this	  would	  further	  confirm	  the	  results	  found	  from	  this	  study,	  by	  showing	  
that	  proliferation-­‐associated	  genes	  are	  altered	  in	  spheroids	  between	  control	  and	  
experimental	  conditions.	  
Using	  separate	  markers	  for	  both	  TA	  cells	  and	  stem	  cells	  for	  whole	  
organoid	  imaging	  would	  also	  be	  interesting.	  Firstly	  to	  compare	  the	  populations	  in	  
the	  enteroids	  and	  the	  spheroids.	  Maybe	  when	  the	  enteroids	  have	  differentiated	  
they	  have	  lost	  the	  pool	  of	  rapidly	  dividing	  TA	  cells,	  and	  instead	  are	  kept	  alive	  by	  a	  
small	  pool	  of	  slow	  cycling	  stem	  cells	  that	  maintain	  the	  basal	  level	  of	  proliferation.	  
Seeing	  if	  both	  TA	  cells	  and	  stem	  cells	  are	  present	  in	  spheroids,	  and	  if	  the	  TA	  cell	  
population	  is	  the	  one	  that	  is	  lost	  after	  environmental	  manipulations,	  to	  cause	  the	  
decrease	  in	  proliferation	  would	  also	  be	  interesting.	  This	  would	  help	  to	  give	  further	  
insight	  into	  how	  the	  proliferation	  is	  changing	  on	  the	  cellular	  level.	  
This	  study	  also	  indicated	  that	  immune	  and	  mesenchymal	  cells	  are	  
important	  in	  regulating	  proliferation.	  It	  would	  be	  interesting	  to	  investigate	  this	  
further	  in	  a	  number	  of	  ways.	  Firstly,	  by	  using	  the	  same	  model,	  and	  culturing	  the	  
organoids	  with	  the	  addition	  of	  an	  inflammatory	  cytokine	  that	  is	  produced	  by	  
immune	  cells	  in	  response	  to	  bacteria	  such	  as	  TNFα,	  and	  assessing	  its	  effect	  on	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proliferation.	  Previous	  research	  has	  indicated	  that	  TNFα,	  produced	  by	  immune	  
cells	  in	  response	  to	  bacteria	  can	  stimulate	  epithelial	  proliferation	  so	  if	  this	  were	  
true	  then	  this	  co-­‐culture	  system	  should	  generate	  an	  increase	  in	  proliferation	  	  in	  
the	  spheroids	  [81;	  40].	  This	  would	  further	  confirm	  that	  increasing	  proliferation	  
requires	  other	  factors	  produced	  by	  cells	  other	  than	  the	  epithelium.	  Alternately,	  
using	  an	  organoid	  model	  where	  the	  mesenchymal	  cells	  are	  present,	  either	  by	  co-­‐
culture	  of	  the	  two	  components	  or	  by	  using	  pluripotent	  stem	  cells,	  which	  when	  
differentiated	  express	  both	  mesenchymal	  and	  epithelial	  cells	  could	  also	  be	  used	  to	  
investigate	  the	  interaction	  between	  the	  two	  components	  and	  their	  effects	  on	  
proliferation	  [86].	  	  
Finally,	  growth	  of	  the	  intestinal	  epithelium	  involves	  a	  balance	  between	  
proliferation	  and	  apoptosis	  [20].	  Usually,	  proliferation	  and	  apoptosis	  are	  matched,	  
so	  no	  overall	  change	  in	  colonic	  structure	  is	  seen	  and	  homeostasis	  is	  maintained	  
[32].	  This	  study	  has	  shown	  that	  bacteria	  are	  able	  to	  decrease	  proliferation,	  but	  if	  
this	  were	  matched	  by	  a	  decrease	  in	  apoptosis,	  little	  overall	  effect	  would	  occur.	  
Conversely,	  if	  it	  were	  accompanied	  with	  an	  increase	  in	  apoptosis,	  this	  would	  cause	  
further	  barrier	  dysfunction,	  microbial	  translocation	  and	  inflammation.	  
Investigating	  changes	  in	  apoptosis	  with	  cleaved	  caspases,	  or	  using	  whole	  mount	  
terminal	  doxynucleotidyl	  transferase	  nick-­‐end	  labelling	  (TUNEL)	  staining,	  using	  
the	  same	  culture	  and	  experimental	  conditions,	  would	  allow	  the	  investigation	  of	  
apoptosis	  in	  both	  the	  enteroids	  and	  the	  spheroids,	  which	  would	  help	  to	  better	  
understand	  the	  changes	  that	  have	  been	  seen	  in	  proliferation	  from	  this	  study.	  	  
Overall	  these	  results	  show	  exciting	  data	  from	  a	  new	  culture	  system,	  and	  
gives	  insight	  not	  only	  into	  colonic	  epithelial	  proliferation	  under	  normal	  conditions,	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but	  also	  how	  the	  epithelium	  is	  able	  to	  respond	  to	  environmental	  changes.	  It	  has	  
revealed	  a	  number	  of	  future	  experiments	  that	  could	  be	  done	  to	  continue	  to	  
understand	  epithelial	  proliferation,	  which	  in	  time	  may	  help	  to	  better	  understand	  a	  
number	  of	  intestinal	  pathologies	  such	  as	  inflammatory	  bowel	  disease.	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